, /PRNewswire/ -- Global talent solutions and business consulting firm Robert Half (NYSE: RHI) has earned two Stevie awards in the 24th Annual American Business Awards. The company has been honored for Best Artificial Intelligence/Machine Learning Solution and for Women in AI Leadership.
Robert Half received Best Artificial Intelligence/Machine Learning Solution for its AI-powered insights engine, a proprietary platform that has transformed how market intelligence is gathered and integrated into Robert Half's thought leadership. Danti Chen, Ph.D., senior vice president of applications, technology and innovation, and head of data science at Robert Half, was named among the Women in AI Leadership.
"This recognition underscores our continued investment in advancing AI-driven innovation that enhances how we deliver insights and value to our customers," said M. Keith Waddell, president and chief executive officer of Robert Half. "We're especially proud of Danti and her team for their critical contributions to these achievements."
Under Chen's leadership, Robert Half has built a world-class data science organization that delivers significant business impact. Her team has launched numerous advanced capabilities, including AI Recommended Client (ARC), which leverages predictive analytics to recommend clients and enhance sales strategies. Chen has also driven ongoing advancements in the company's AI-powered matching platform and led the development of generative AI solutions across the organization.
"This honor reflects Danti's outstanding leadership in advancing innovation at Robert Half," said James Johnson, executive vice president and chief technology officer of Robert Half. "We're proud of the impact her team has made in developing differentiated tools and solutions that enhance how we operate and serve our clients."
The American Business Awards is the premier business awards program in the United States. More than 3,700 nominations from organizations of all sizes and in virtually every industry were submitted for consideration in a wide range of categories. Robert Half has also been named one of Fortune's 2026 America's Most Innovative Companies and a winner of the 2025 CIO 100 Award.
FAQs
How is Robert Half using AI and technology to support clients and talent?
Robert Half leverages advanced machine learning and proprietary data to match professionals with opportunities quickly and accurately, even as generative AI reshapes how job seekers present themselves.
What makes Robert Half's AI unique?
Robert Half combines advanced AI technologies and proprietary data with deep industry expertise from its talent solutions professionals. Its AI tools are designed to augment capabilities and improve productivity and accuracy while maintaining a personalized, high-touch experience for clients and candidates.
How can staffing firms help employers navigate AI-driven hiring challenges?
Staffing firms can help streamline candidate evaluations, reduce hiring risk and verify candidate authenticity through proprietary performance data and candidate validation processes.
About Robert Half
Robert Half (NYSE: RHI) is the world's first and largest specialized talent solutions and business consulting firm, connecting highly skilled job seekers with rewarding opportunities at great companies. We offer contract talent and permanent placement solutions in the fields of finance and accounting, technology, marketing and creative, legal, and administrative and customer support, and we also provide executive search services. Robert Half is the parent company of Protiviti®, a global consulting firm that delivers internal audit, risk, business and technology consulting solutions. In the past 12 months, Robert Half, including Protiviti, has been named one of the Fortune® Most Admired Companies™ and 100 Best Companies to Work For. Explore talent solutions, research and insights at roberthalf.com.
AI blind spots are increasing cybersecurity, operational and third‑party risk as adoption accelerates
, /PRNewswire/ -- As artificial intelligence becomes embedded across core business functions, many organizations still lack a clear understanding of how and where AI is being used across their enterprises. According to new research from global consulting firm Protiviti, nearly half (47%) of large organizations report they do not have full visibility into employee AI tool usage, creating growing challenges related to cybersecurity, governance and operational risk.
The findings come from the fourth Protiviti AI Pulse Survey, titled "No Visibility, No Confidence," which examines how C‑suite executives, board members and IT leaders are managing AI adoption, oversight and risk as usage expands across the enterprise and into third‑party platforms.
AI Adoption Is Outpacing Oversight and Governance
The survey reveals a widening gap between the pace of AI adoption and organizations' ability to govern it effectively:
47% of large organizations lack full visibility into AI tools used by employees. 65% report challenges with "shadow AI," where systems are deployed or used without proper oversight. Only four in 10 organizations have a formal AI governance framework in place. Even among large organizations, one in three lack a formal framework, underscoring that resources alone do not guarantee effective oversight. According to the survey, organizations that have a formal AI governance framework in place report:
Greater visibility into AI usage Higher confidence in managing AI-related risk Stronger recognition of AI-driven cyber and operational threats at the executive level "Organizations can't manage what they can't see," said Sameer Ansari, Global Lead, CISO Solutions at Protiviti. "As AI becomes more deeply embedded across the enterprise, leaders are often making decisions based on an incomplete picture. That lack of visibility makes it significantly harder to secure systems, enforce governance and build trust in AI-enabled outcomes."
Visibility Gaps Expose Organizations to Higher Cyber and Operational Risk
The research also highlights a disconnect between executive leadership and IT teams when it comes to assessing AI-related risk:
Close to half of IT leaders (45%) believe AI has increased cyber risk significantly, versus fewer than one in three (30%) executives and board members. IT teams, which are closer to day‑to‑day AI usage, are more likely to identify gaps that extend beyond internal systems to include vendor platforms, embedded AI tools and third‑party services. These blind spots can delay decision‑making, slow investment in controls and limit an organization's ability to respond quickly to emerging AI-driven threats.
As AI Scales, Visibility and Control Must Scale with It
As organizations move beyond early experimentation and their use of AI more significantly impacts customers, financial processes, and other critical elements of the business, the importance of scalable governance, accountability and continuous AI tool monitoring grows.
"As AI extends deeper into business processes and third‑party ecosystems, organizations need to revisit and strengthen controls," Ansari said. "Those that invest early in governance, transparency and accountability will be far better positioned to scale AI securely, respond to threats and sustain long‑term value."
Methodology
The Protiviti AI Pulse Survey was conducted in February 2026 and includes responses from approximately 345 C‑suite executives, board members and IT leaders across global organizations. The survey, the fourth in an ongoing series of surveys designed to assess the ever-evolving AI landscape, looks at how businesses are addressing AI-related cybersecurity, governance and resilience challenges.
Protiviti has also published an AI Governance FAQ guide. It provides practical, cross-functional perspectives on the governance of AI systems and data, while also addressing broader implications across compliance, cybersecurity, finance, people and culture, customer experience, operations, internal audit and board oversight.
About Protiviti
Protiviti (www.protiviti.com) is a global consulting firm that helps clients transform and protect their businesses, and respond to planned and unexpected events. Through a network of more than 90 offices in over 25 countries, Protiviti and its independent and locally owned member firms deliver deep expertise and tailored capabilities across technology, artificial intelligence, data, operations, finance, legal, compliance, HR, marketing, digital, risk, and internal audit – enabling organizations to accelerate innovation, navigate risks and safeguard what matters most.
Named to the Fortune 100 Best Companies to Work For® list since 2015, Protiviti Inc. has served more than 80 percent of Fortune 100 and nearly 80 percent of Fortune 500 companies. The firm also works with government agencies and smaller, growing companies, including those looking to go public. Protiviti Inc. is a wholly owned subsidiary of Robert Half (NYSE: RHI).
Only 12% say they have the talent they need to complete high-priority projects 54% say AI-generated applications has made hiring more difficult , /PRNewswire/ -- May is National Small Business Month, and new research from talent solutions and business consulting firm Robert Half shows many small business leaders are optimistic about the year ahead, even as hiring grows more complex amid widening skills gaps and evolving technology.
According to data from Robert Half, small companies are driving hiring demand in the U.S. A survey of more than 250 U.S. small business leaders (fewer than 100 employees) shows that 76% are confident about their company's hiring outlook for the year ahead. Yet 47% say finding skilled talent is more difficult than one year ago, and only 12% say they have the talent needed to complete high-priority projects.
AI adoption and skills gaps intensify hiring challenges
Over the next 2 years, 41% of small business leaders expect a net increase in jobs at their organizations amid the rise of AI. At the same time, more than half (56%) report significant skills gaps on their teams, and 58% say those gaps have increased over the past year.
"Widening skills gaps are making it harder for small businesses to successfully compete and grow," said Dawn Fay, operational president of Robert Half. "Organizations that adapt their hiring strategies, invest in upskilling and leverage specialized expertise are better positioned to compete in today's business landscape."
How have AI-generated candidate materials complicated hiring?
The rapid adoption of AI tools among job seekers is introducing new hiring challenges. More than half of small business leaders (54%) say AI-generated applications have made hiring more difficult, primarily due to an influx of homogeneous applications that are difficult to authenticate.
As a result, many small businesses are seeking support from external partners, and 56% are more likely to work with a staffing firm due to AI-related hiring challenges. Of those, 84% report that those partners have been effective in addressing these obstacles—particularly by validating candidate information and identifying specialized talent for critical roles.
"Many small businesses don't have the resources to manage the surge in applications that can be difficult to authenticate," Fay added. "While AI has made job searching more efficient, it has also increased the need for trusted human experts who can validate skills and deliver specialized candidates."
Small businesses drive hiring demand
Despite these challenges, small businesses remain a key source of job openings in the U.S. Robert Half data from Q1 2026 shows that among companies with fewer than 600 employees, the smallest organizations account for the largest share of job openings across 5 professional fields—led by legal (66%), administrative and customer support (64%) and marketing and creative (63%).
Robert Half's Staffing for Small Businesses offers additional insights for navigating today's hiring environment.
FAQ:
Why is AI making the hiring process longer for employers?
AI-generated resumes and increased applicant volume enabled by AI are creating more work for hiring managers. Hiring teams are spending more time verifying skills, assessing authenticity and evaluating applicants who end up not having the required skills.
Why are small businesses confident about hiring but still struggling to fill critical roles?
Many small business leaders remain optimistic about growth this year but only a small share has the specialized talent they need. Growing skills gaps may also contribute to their ability to hire critical roles and move key initiatives forward.
How are small businesses adapting to a tighter talent market and navigating AI-driven hiring challenges?
Many are adjusting their hiring strategies by investing in upskilling or partnering with external experts. Staffing firms can help streamline candidate evaluations, reduce hiring risk and verify skills.
Are AI-generated resumes always inaccurate or misleading?
Not all AI-generated applications are inaccurate or misleading. Many candidates use AI responsibly to improve clarity or grammar. The challenge for employers is the volume of unverified applications and the difficulty distinguishing authentic experience from AI-fabricated content.
About the research
The research is gathered from a survey developed by Robert Half and conducted by an independent research firm in November 2025. The survey contains responses from more than 250 small business leaders with 100 or fewer employees in the United States.
About Robert Half
Robert Half (NYSE: RHI) is the world's first and largest specialized talent solutions and business consulting firm, connecting highly skilled job seekers with rewarding opportunities at great companies. We offer contract talent and permanent placement solutions in the fields of finance and accounting, technology, marketing and creative, legal, and administrative and customer support, and we also provide executive search services. Robert Half is the parent company of Protiviti®, a global consulting firm that delivers internal audit, risk, business and technology consulting solutions. In the past 12 months, Robert Half, including Protiviti, has been named one of the Fortune® Most Admired Companies™ and 100 Best Companies to Work For. Explore talent solutions, research and insights at roberthalf.com.
On May 13, 2026, Robert Half Inc (RHI) shares fell 4.5% to $24.90, continuing a downward trend that has seen the stock decline 43.7% over the past year. The sha
Combining Rajant's Kinetic Mesh® networking foundation with RHI's Cowbell platform and Latent AI's edge-native AI to deliver resilient intelligence in DDIL environments.
PRINCETON, N.J. & MALVERN, Pa.--(BUSINESS WIRE)--Defense and industrial operators face a persistent problem: AI that performs well in controlled demonstrations but fails to deliver reliable, real-time intelligence in denied, disrupted, intermittent, or limited (DDIL) environments. The result is delayed decisions, stranded assets, and lost operational advantage.
Latent AI today announced a strategic partnership with Rajant Health Incorporated (RHI), a majority-owned subsidiary of Rajant Corporation, that solves this challenge at fleet scale.
Rajant provides the core Kinetic Mesh® networking platform that keeps systems connected in motion. RHI extends that foundation with the Cowbell distributed edge platform, unifying resilient mesh networking, distributed compute, local data pipelines, and workload orchestration. Latent AI multiplies that capability with an edge-native platform that optimizes AI for target hardware and enables secure, over-the-air deployment, monitoring, and updates, even when cloud connectivity is unavailable.
Together, the three layers deliver mission-ready AI that operates reliably across heterogeneous hardware in the harshest environments, without requiring on-site engineering teams.
The combined solution enables organizations to:
Deploy and update AI models across distributed fleets with minimal reengineering Run real-time inference locally during fully disconnected or bandwidth-constrained operations Maintain continuous model lifecycle management without on-site AI expertise Adapt intelligence in real time as mission conditions change Latent AI has proven these capabilities in U.S. Army Project Linchpin (reducing deployment timelines from weeks to minutes) and U.S. Navy Project AMMO (33% faster model update cycles in connectivity-denied environments).
“AI at the edge is not just a model deployment problem; it is a lifecycle problem across hardware, data, connectivity, and operational constraints,” said Jags Kandasamy, CEO and co-founder of Latent AI. “RHI’s Cowbell gives AI a true operational foundation. Together, we’re enabling AI to deploy, adapt, and sustain itself at fleet scale, wherever the mission demands it.”
Robert J. Schena, CEO of RHI, added: “This partnership reflects a fundamental shift from infrastructure that connects systems to platforms that operationalize intelligence. With Cowbell, RHI provides the distributed execution layer, and Latent AI ensures intelligence can move, adapt, and scale across that fabric.”
This joint solution was announced and showcased recently at the Rajant 2026 Partner Summit in Wickenburg, Arizona.
About Latent AI Latent AI is the trusted edge AI company delivering mission-critical intelligence at the tactical edge. Our proven, edge-native solutions enable defense and industrial organizations to deploy, adapt, and sustain AI in denied and contested environments, interoperable across platforms, field-updatable in real time, and built for operators of every skill level. Trusted by the U.S. Department of Defense. Visit latentai.com.
About Rajant Health Incorporated RHI is a provider of integrated edge intelligence platforms combining resilient wireless mesh radios, distributed compute platforms, applications, and AI to enable real-time awareness and decision support in complex, dynamic, mission-critical environments. Visit rajanthealth.com.
Advancing “Flying Cowbell” as a mobility-native, distributed compute and autonomy fabric for multi-domain operations
MALVERN, Pa. & MELBOURNE, Fla.--(BUSINESS WIRE)--Rajant Health (RHI), a majority-owned subsidiary of Rajant Corporation that extends its Kinetic Mesh® networking platform with distributed edge compute and autonomy capabilities, and Chord Robotics, a pioneer in collaborative control and multi-platform orchestration, today announced an expanded partnership to advance the Cowbell platform with enhanced “Flying Cowbell” capabilities.
This collaboration integrates Cowbell’s distributed edge compute and transport-agnostic networking fabric with Chord Robotics’ TEMPO™ software. The result is scalable, real-time collaborative autonomy across highly mobile and connectivity-constrained environments, enabling one-to-many control of mixed fleets operating across air, land, and sea.
From Connectivity to Distributed Autonomous Execution
Cowbell is architected as a distributed edge platform where compute, storage, and applications operate directly across clusters of nodes spanning ground vehicles, maritime assets, and aerial systems. With “Flying Cowbell,” mobile nodes, UAS and USVs, become active participants in the compute and autonomy fabric rather than just network relays.
Key capabilities include:
Distributed workload execution across mobile edge nodes Dynamic cluster formation across air, land, and sea Transport-agnostic operation across heterogeneous radios Edge autonomy under intermittent or disconnected conditions Making Collaborative Autonomy Scalable
TEMPO enables intelligent one-to-many control of mixed fleets while maintaining fully distributed, edge-native autonomy.
Key TEMPO capabilities include:
Intelligent, multi-domain, one-to-many control of mixed unmanned systems across air, ground, and sea platforms Fully distributed autonomy where every vehicle understands the mission and makes independent decisions Platform-agnostic collaborative architecture that uses best-of-breed hardware, autonomy, and perceptual AI By combining TEMPO with Cowbell, the system gains the full benefit of Rajant’s InstaMesh® networking, allowing orchestration to scale seamlessly as fleets grow and networks shift, even without centralized infrastructure.
“Flying Cowbell” represents a fundamental shift from static infrastructure to mobility-native distributed systems, where aerial, maritime, and ground assets collectively form a unified compute, sensing, and autonomy fabric. This enables persistent coverage, dynamic mission adaptation, and rapid scaling from small teams to large autonomous fleets.
Executive Perspectives
“Built on Rajant’s Kinetic Mesh® networking platform, RHI’s Cowbell was designed as a distributed execution layer at the edge, not just a connectivity solution,” said Robert J. Schena, CEO of Rajant Health. “With ‘Flying Cowbell,’ we are extending that execution fabric across mobile systems, enabling applications, autonomy, and data to move with the mission rather than depend on fixed infrastructure.”
“By combining TEMPO with Rajant’s proven InstaMesh® scalable networking capabilities and their embedded Cowbell edge platform, we’re able to scale autonomous heterogeneous fleets across challenging, infrastructure-denied environments,” shares James Cooney, Chord Robotics CEO. “This partnership brings together the connectivity, compute, and collaborative autonomy needed to let a single operator orchestrate mixed fleets across all domains.”
About Rajant Health Incorporated (RHI)
RHI delivers integrated edge intelligence platforms combining resilient wireless mesh, distributed compute, applications, and AI for real-time awareness and decision support in complex, dynamic environments. Visit rajanthealth.com.
About Chord Robotics
Chord Robotics delivers TEMPO™, a collaborative control software platform enabling intelligent, multi-domain, large-scale orchestration of mixed fleet unmanned systems. Proven across multiple government and commercial programs, TEMPO provides one-to-many control of air, ground, and sea platforms, synchronizing unmanned tasks to execute complex, adaptive, and dynamic operations. Visit chordrobotics.com
Advancing “Flying Cowbell” as a mobility-native, distributed compute and autonomy fabric for multi-domain operations
MALVERN, Pa. & MELBOURNE, Fla.--(BUSINESS WIRE)--Rajant Health (RHI), a majority-owned subsidiary of Rajant Corporation that extends its Kinetic Mesh® networking platform with distributed edge compute and autonomy capabilities, and Chord Robotics, a pioneer in collaborative control and multi-platform orchestration, today announced an expanded partnership to advance the Cowbell platform with enhanced “Flying Cowbell” capabilities.
This collaboration integrates Cowbell’s distributed edge compute and transport-agnostic networking fabric with Chord Robotics’ TEMPO™ software. The result is scalable, real-time collaborative autonomy across highly mobile and connectivity-constrained environments, enabling one-to-many control of mixed fleets operating across air, land, and sea.
From Connectivity to Distributed Autonomous Execution
Cowbell is architected as a distributed edge platform where compute, storage, and applications operate directly across clusters of nodes spanning ground vehicles, maritime assets, and aerial systems. With “Flying Cowbell,” mobile nodes, UAS and USVs, become active participants in the compute and autonomy fabric rather than just network relays.
Key capabilities include:
Distributed workload execution across mobile edge nodes Dynamic cluster formation across air, land, and sea Transport-agnostic operation across heterogeneous radios Edge autonomy under intermittent or disconnected conditions Making Collaborative Autonomy Scalable
TEMPO enables intelligent one-to-many control of mixed fleets while maintaining fully distributed, edge-native autonomy.
Key TEMPO capabilities include:
Intelligent, multi-domain, one-to-many control of mixed unmanned systems across air, ground, and sea platforms Fully distributed autonomy where every vehicle understands the mission and makes independent decisions Platform-agnostic collaborative architecture that uses best-of-breed hardware, autonomy, and perceptual AI By combining TEMPO with Cowbell, the system gains the full benefit of Rajant’s InstaMesh® networking, allowing orchestration to scale seamlessly as fleets grow and networks shift, even without centralized infrastructure.
“Flying Cowbell” represents a fundamental shift from static infrastructure to mobility-native distributed systems, where aerial, maritime, and ground assets collectively form a unified compute, sensing, and autonomy fabric. This enables persistent coverage, dynamic mission adaptation, and rapid scaling from small teams to large autonomous fleets.
Executive Perspectives
“Built on Rajant’s Kinetic Mesh® networking platform, RHI’s Cowbell was designed as a distributed execution layer at the edge, not just a connectivity solution,” said Robert J. Schena, CEO of Rajant Health. “With ‘Flying Cowbell,’ we are extending that execution fabric across mobile systems, enabling applications, autonomy, and data to move with the mission rather than depend on fixed infrastructure.”
“By combining TEMPO with Rajant’s proven InstaMesh® scalable networking capabilities and their embedded Cowbell edge platform, we’re able to scale autonomous heterogeneous fleets across challenging, infrastructure-denied environments,” shares James Cooney, Chord Robotics CEO. “This partnership brings together the connectivity, compute, and collaborative autonomy needed to let a single operator orchestrate mixed fleets across all domains.”
About Rajant Health Incorporated (RHI)
RHI delivers integrated edge intelligence platforms combining resilient wireless mesh, distributed compute, applications, and AI for real-time awareness and decision support in complex, dynamic environments. Visit rajanthealth.com.
About Chord Robotics
Chord Robotics delivers TEMPO™, a collaborative control software platform enabling intelligent, multi-domain, large-scale orchestration of mixed fleet unmanned systems. Proven across multiple government and commercial programs, TEMPO provides one-to-many control of air, ground, and sea platforms, synchronizing unmanned tasks to execute complex, adaptive, and dynamic operations. Visit chordrobotics.com
On May 21, 2026, Robert Half Inc (RHI) shares rose 3.6% today, closing at $27.18. The stock has experienced a 52-week range of $21.83 to $46.69, reflecting sign
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- M. Keith Waddell, president and chief executive officer of global talent solutions and business consulting firm Robert Half Inc. (NYSE: RHI), will participate in a fireside chat at the Baird Global Consumer, Technology & Services Conference in New York City on Tuesday, June 2, 2026, at 3:10 p.m. ET. Mr. Waddell also will host investor meetings throughout the day.
Robert Half's investor presentation for the first quarter 2026 is available on the company's website at roberthalf.com/investor-center/events-and-presentations.
About Robert Half
Robert Half is the world's first and largest specialized talent solutions and business consulting firm, connecting highly skilled job seekers with rewarding opportunities at great companies. We offer contract talent and permanent placement solutions in the fields of finance and accounting, technology, marketing and creative, legal, and administrative and customer support, and we also provide executive search services. Robert Half is the parent company of Protiviti, a global consulting firm that delivers internal audit, risk, business and technology consulting solutions. In the past 12 months, Robert Half has been recognized as one of America's Most Innovative Companies by Fortune and, with Protiviti, has been named one of the Fortune® Most Admired Companies™ and 100 Best Companies to Work For. Explore our comprehensive solutions, research and insights at roberthalf.com.
Global consulting firm named one of the 25 Best Large Companies for its people-focused culture
, /PRNewswire/ -- Protiviti, a global consulting firm, has been named to the Fortune Best Workplaces in the Bay Area 2026™ list, earning recognition among the 25 Best Large Companies headquartered in the San Francisco Bay Area. This marks the eighth time Protiviti has been named to the list.
"We're proud to be recognized again in one of the most competitive talent markets in the country," said Scott Redfearn, EVP, global human resources, Protiviti. "This honor reflects what we work hard to build every day: a culture where our people are listened to, supported in their growth, and trusted to do great work. When our teams feel valued and included, they bring their best to our clients and our communities."
The Fortune Best Workplaces in the Bay Area list is based on more than 70,000 confidential survey responses from employees at Great Place to Work Certified™ companies, providing a comprehensive assessment of their workplace experience. Honorees were evaluated on their ability to deliver consistently positive outcomes for their people, regardless of role, tenure or position.
"Congratulations to the Fortune Best Workplaces in the Bay Area," said Michael C. Bush, CEO of Great Place To Work. "By focusing on people, these companies are more resilient and effective in a business environment that demands speed, innovation, and agility."
Named in 2026 to the Fortune 100 Best Companies to Work For® list for 12 years, Protiviti has also been named a Glassdoor Best Place to Work and one of Forbes America's Best Midsize Employers. Additionally, the company has been recognized by Business Insider and Forbes as a top management consulting firm.
To learn more about Protiviti's employee experience, visit Life at Protiviti.
About Protiviti
Protiviti (www.protiviti.com) is a global consulting firm that helps clients transform and protect their businesses, and respond to planned and unexpected events. Through a network of more than 90 offices in over 25 countries, Protiviti and its independent and locally owned member firms deliver deep expertise and tailored capabilities across technology, artificial intelligence, data, operations, finance, legal, compliance, HR, marketing, digital, risk, and internal audit — enabling organizations to accelerate innovation, navigate risks and safeguard what matters most.
Named to the Fortune 100 Best Companies to Work For® list since 2015, Protiviti Inc. has served more than 80 percent of Fortune 100 and nearly 80 percent of Fortune 500 companies. The firm also works with government agencies and smaller, growing companies, including those looking to go public. Protiviti Inc. is a wholly owned subsidiary of Robert Half (NYSE: RHI).
Protiviti is not licensed or registered as a public accounting firm and does not issue opinions on financial statements or offer attestation services.
All trademarks are property of their respective owners.
New artificial intelligence solution improves questionnaire response efficiency, consistency, and compliance through human-in-the-loop oversight
, /PRNewswire/ -- Global consulting firm Protiviti has been awarded a second U.S. patent by the U.S. Patent and Trademark Office for its innovation, "Systems and Methods for Automated Data Set Matching Services."
The patented technology leverages artificial intelligence (AI) and machine learning to help organizations automate and streamline high-volume questionnaire response processes, including third-party risk assessments, security questionnaires, regulatory requests, and client due diligence.
The system uses machine learning to analyze, categorize and map large datasets of structured questions into relevant domains, then identifies similarities across new and historical questions to surface the most relevant preapproved responses.
Scalable use cases across industries
While initially developed for cybersecurity and third-party risk questionnaires, the AI-powered system can be applied broadly across:
Vendor and supplier risk management Regulatory and compliance reporting ESG and sustainability questionnaires Client onboarding and due diligence Internal audit and controls documentation Why it matters
Organizations across industries face growing pressure to respond quickly and accurately to large volumes of complex, repetitive questionnaires. Manual processes are time-intensive, inconsistent, and difficult to scale.
Protiviti's patented solution addresses this challenge by enabling teams to:
Automatically classify and organize questions using AI Match new questions to previously approved responses from a centralized answer library Reduce duplication and manual effort across teams Improve consistency, accuracy, and turnaround time Maintain compliance with built-in human review workflows Executive perspective
"This innovation addresses a common and costly challenge for organizations—responding to hundreds of similar questionnaires from customers, regulators, and partners," said Scott Laliberte, managing director at Protiviti and co-inventor of the patent.
"By applying AI to identify and deliver the most relevant responses quickly—while keeping humans in control—we help organizations increase efficiency, improve response quality, and reduce operational burden without sacrificing accuracy or compliance."
"We weren't trying to reinvent everything; we focused on combining new AI approaches with a better way to reuse existing knowledge," said Kalabe Haile, a Protiviti senior manager who played a key role in designing the patented technology. "That's what really unlocks scale and consistency."
Driving innovation through Protiviti's patent program
This patent reflects the continued momentum of Protiviti's Global Patent Program, launched in 2022 to accelerate innovation and develop practical solutions to real-world client challenges.
The program encourages employees to:
Identify common business pain points Experiment with AI and advanced technologies Collaborate across disciplines Transform ideas into patentable, client-ready solutions About Protiviti
Protiviti is a global consulting firm that helps clients transform and protect their businesses and respond to planned and unexpected events. Through a network of more than 90 offices in over 25 countries, Protiviti and its independent and locally owned member firms deliver deep expertise and tailored capabilities across technology, artificial intelligence, data, operations, finance, legal, compliance, HR, marketing, digital, risk, and internal audit—enabling organizations to accelerate innovation, navigate risks and safeguard what matters most.
Named to the Fortune 100 Best Companies to Work For® list since 2015, Protiviti Inc. has served more than 80 percent of Fortune 100 and nearly 80 percent of Fortune 500 companies. The firm also works with government agencies and smaller, growing companies, including those looking to go public. Protiviti Inc. is a wholly owned subsidiary of Robert Half (NYSE: RHI)
Hamilton Lane (HLNE - Free Report) shares soared 7.4% in the last trading session to close at $99.07. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 4.7% loss over the past four weeks.
As major banks release their first-quarter 2026 results, the outlook for the finance sector has been lifted with expectations of strong investment banking activity, trading revenues, and deal-making momentum. Moreover, with improving outlook for fee-related earnings and renewed optimism around private equity and credit activity, investors are now rotating into beaten-down alternative asset managers. These are probably the reasons why the HLNE stock gained in last day’s trading session.
This private-market investment firm is expected to post quarterly earnings of $1.40 per share in its upcoming report, which represents a year-over-year change of +15.7%. Revenues are expected to be $199.94 million, up 1% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Hamilton Lane, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on HLNE going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Hamilton Lane belongs to the Zacks Financial - Investment Management industry. Another stock from the same industry, GCM Grosvenor Inc. (GCMG - Free Report) , closed the last trading session 3.3% higher at $10.04. Over the past month, GCMG has returned -6.1%.
For GCM Grosvenor, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.19. This represents a change of +5.6% from what the company reported a year ago. GCM Grosvenor currently has a Zacks Rank of #2 (Buy).
Over 25 promotions and appointments to Managing Director and Principal reflect the firm's continued growth and expansion of its product offerings and client and investment teams , /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced senior promotions and new appointments across its Investment, Client Solutions, Portfolio Management, Legal, Finance and Operations Teams.
The firm recognized the promotions of the following individuals to Managing Director:
Anastasia Di Carlo, Client Solutions Brian Reilly, Taft-Hartley Emily Lozada, Investment Legal Jan Verstraete, Secondary Investments Kaylin Liu, Fund Accounting Nelda Chang, Direct Equity Investments Scott Thomas, Client Solutions William Bannard, Portfolio Management Group In addition, the firm promoted the following individuals to Principal:
Agnieszka Lor, Account Execution Charlotte Riley, Human Resources Da Eun Kim, Client Solutions Jeff Benson, Client Solutions Jeff Straus, Secondary Investments Jerome Kamm, Direct Equity Investments Kristen McCarthy, Digital Business Transformation Kyle McGinnis, Direct Equity Investments Lauren Williamson, Client Solutions Steve Caplan, Direct Equity Investments All promotions were effective as of April 1, 2026.
The firm also made a number of new appointments, including Christopher Alpaugh as Managing Director, Head of National Sales. Based in New York, his focus is on the development and execution of the firm's U.S. evergreen sales strategy, and he reports to Beth Nardi, Head of U.S. Private Wealth. In addition, Alexandre Hökfelt joined the firm as a Managing Director on the Direct Credit Investment team in London, where he oversees the firm's UK and European Direct Credit platform and leads investment sourcing and due diligence efforts. Hökfelt reports to Tom Kerr, Co-Head of Investments and Co-Head of Secondaries.
Since the start of 2026, the firm has made the following Principal appointments:
Ian Meyers, Head of Enterprise Relationships James Wu, Head of Data Integrity Joseph Montelione, Treasury Kenneth Lower, Fund Accounting Maria Sala, Multi-Strategy, Evergreen Product Specialist Sean Abbott, Portfolio Management Group Erik Hirsch, Co-CEO at Hamilton Lane, commented, "We are happy to recognize these well deserved promotions, which are a reflection of our strong culture, standout talent and the dedication of an exceptional group of leaders, as well as welcome this new group of senior professionals to Hamilton Lane."
Juan Delgado, Co-CEO at Hamilton Lane, added, "Our growing leadership bench correlates directly to our ability to continue raising the bar for our clients around the world, as we seek to deliver best in class service and support the evolving needs of more than 2,600 institutional and private wealth investors worldwide. Congratulations to everyone recognized."
The firm was recognized for a number of awards recently, including being named to Pensions & Investments' 'Best Places to Work in Money Management' list for the 14th consecutive year and winning several awards across Asia: 'Best Asian Private Markets Manager' by Asia Asset Management; 'Alternatives House of the Year' by Fund Selector Asia; and was named to Korea Economic Daily's Best Asset Managers list.
About Hamilton Lane
Hamilton Lane (Nasdaq: HLNE) is one of the largest private markets investment firms globally, providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 780 professionals operating in offices throughout North America, Europe, Asia Pacific and the Middle East. Hamilton Lane has $1.0 trillion in assets under management and supervision, composed of $146.1 billion in discretionary assets and $871.5 billion in non-discretionary assets, as of December 31, 2025. Hamilton Lane specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors and geographies. For more information, please visit our website or follow us on LinkedIn.
The Hamilton Lane Credit Income Fund is now available to institutional and private wealth investors via the interval fund structure The firm's Private Infrastructure Fund is now offered in an interval fund structure and is also available in a tokenized format through Republic's digital platform , /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE) today announced the launch of the Hamilton Lane Credit Income Fund ("HLCIF") and the conversion of the Hamilton Lane Private Infrastructure Fund ("HLPIF") to an interval fund structure.
Structured as interval funds, HLCIF and HLPIF are designed to offer institutional and private wealth investors in the U.S. access to private market strategies with investor‑friendly features, including 1099 tax reporting, quarterly limited liquidity, daily NAV pricing and investment minimums as low as $2,500 in certain share classes. Registered under the Investment Company Act of 1940, the interval funds aim to provide greater flexibility and accessibility to the asset class, while maintaining a conservative investment approach focused on risk management and volatility mitigation. Investors also benefit from quarterly repurchase offers, which seek to provide periodic liquidity without the extended lockups typically associated with closed‑end vehicles.
Beth Nardi, Head of U.S. Private Wealth at Hamilton Lane, commented, "These funds advance our ongoing commitment to expanding access to private markets and enhancing the investing experience, regardless of structure. Our aim is to meet advisors and their clients where they are by providing diversified, high‑quality exposure, greater transparency and streamlined access to private markets."
HLCIF
The firm's Credit Income Fund was declared effective by the SEC last month and has seen strong investor interest thus far, having already reached more than $350 million in commitments1.
HLCIF provides curated access to a diversified portfolio of middle‑market senior loans, sourced through Hamilton Lane's global multi‑manager platform rather than index‑based exposure. HLCIF is supported by the firm's 20+ years of direct credit investing experience and its extensive global GP network2.
HLPIF
Initially launched in October 2024, the Hamilton Lane Private Infrastructure Fund, which has been converted to an interval fund structure, will continue its existing infrastructure strategy focused on co‑investments and secondaries. Building on the firm's $90 billion platform3 and more than 25 years of experience in the infrastructure space, HLPIF seeks to capitalize on unique middle-market opportunities across the telecommunications, transportation, power & energy, environmental and renewables sectors.
In addition, as part of Hamilton Lane's ongoing effort to modernize access to private markets through technology, HLPIF is now also available in a tokenized format via Republic's digital investment platform.
Since launching its global evergreen platform in 2019, Hamilton Lane has built a suite of 12 funds representing nearly $18 billion in assets under management4.
1 Commitments are across strategic institutional and private wealth groups as well as the firm's balance sheet as of April 20, 2026
2Hamilton Lane has more than 400 active GP relationships within its private credit platform as of 1/31/26
3 Comprised of $7.6 billion in assets under management and $82.2 billion in assets under supervision as of 12/31/26
4Assets Under Management is calculated as the net asset value (NAV) as of February 28,2026 plus net subscriptions received for the March 2, 2026 trade date for all evergreen funds managed by Hamilton Lane.
About Hamilton Lane
Hamilton Lane (Nasdaq: HLNE) is one of the largest private markets investment firms globally, providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 780 professionals operating in offices throughout North America, Europe, Asia Pacific and the Middle East. Hamilton Lane has $1.0 trillion in assets under management and supervision, composed of $146.1 billion in discretionary assets and $871.5 billion in non-discretionary assets, as of December 31, 2025. Hamilton Lane specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors and geographies. For more information, please visit our website or follow us on LinkedIn.
Important Information
Private markets investments involve significant risks, including illiquidity and the absence of daily market pricing, which may contribute to performance differences versus public benchmarks.
Investors should carefully consider the investment objectives, risks, charges and expenses of the Fund before investing. You should consider the Funds' investment objectives, risks, charges, and expenses carefully before investing. For a prospectus that contains this and other information about the Fund, call 1 (888) 882-8212. Please read the prospectus carefully before investing. Investing in the Fund involves risk including loss of principal.
Past performance does not guarantee future results, and investing in the Hamilton Lane Credit Income Fund and Hamilton Lane Private Infrastructure Fund (the "Funds") involve substantial risk, including the possible loss of principal, may not be suitable for all investors. Shares are speculative, illiquid, and not publicly traded, with limited repurchase opportunities and no expected secondary market. Redemptions may be made in kind and may include hard-to-sell securities. As non-diversified, closed-end interval funds, the Funds will conduct quarterly repurchase offers of at least 5% of outstanding shares, but only a limited portion will be eligible. The Funds should be viewed as a long-term investment suitable only for investors who can tolerate a high degree of risk and do not require liquidity.
HLCIF is newly formed and has no performance history. HLPIF has a limited operating history. The Funds' shares have no history of public trading. Results may be affected by market volatility, interest rate changes, leverage, and other economic factors. Distributions are not guaranteed and may be funded from sources such as borrowings or offering proceeds, which may constitute a return of capital. The Funds' success depends on the Adviser's ability to source suitable investments, including through private underlying vehicles ("Portfolio Funds"), which may involve illiquidity, valuation uncertainty, limited operating histories, unfunded commitments, and reduced transparency. The Funds may also invest in below-investment-grade securities, which carry higher default, valuation, liquidity, and volatility risks. Funds' shares are not government-insured and do not represent a complete investment program. Hamilton Lane Advisors, LLC is the Fund's investment advisor. Distribution Services, LLC serves as the Funds' Distributor and is not affiliated with any of the entities mentioned.
Forward-Looking Statements
Some of the statements in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Words such as "will," "expect," "believe," "estimate," "continue," "anticipate," "intend," "plan" and similar expressions, or the negative version of these words or other comparable words, are intended to identify these forward-looking statements. Forward-looking statements discuss management's current expectations and projections relating to, among other things, our financial position, results of operations, plans, objectives, future performance and business. All forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause actual results to be materially different. For more information regarding the risks and uncertainties that Hamilton Lane faces, you should refer to the "Risk Factors" detailed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 and in our subsequent reports filed from time to time with the Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov. The forward-looking statements included in this release are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information or future events, except as otherwise required by law.
, /PRNewswire/ -- Hamilton Lane Incorporated (Nasdaq: HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2026 before the market opens on Thursday, May 21, 2026. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website.
Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 21 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here at least 15 minutes prior to the start of the call. This feature will be in listen-only mode.
A replay of the webcast will be available approximately two hours after the live broadcast for a period of one year, and can be accessed in the same manner as the live webcast on the Hamilton Lane Shareholders website.
About Hamilton Lane
Hamilton Lane (Nasdaq: HLNE) is one of the largest private markets investment firms globally, providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 780 professionals operating in offices throughout North America, Europe, Asia Pacific and the Middle East. Hamilton Lane has $1.0 trillion in assets under management and supervision, composed of $146.1 billion in discretionary assets and $871.5 billion in non-discretionary assets, as of December 31, 2025. Hamilton Lane specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors and geographies. For more information, please visit our website or follow Hamilton Lane on LinkedIn.
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Hamilton Lane (HLNE - Free Report) , which belongs to the Zacks Financial - Investment Management industry.
This private-market investment firm has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 31.84%.
For the last reported quarter, Hamilton Lane came out with earnings of $1.55 per share versus the Zacks Consensus Estimate of $1.28 per share, representing a surprise of 21.09%. For the previous quarter, the company was expected to post earnings of $1.08 per share and it actually produced earnings of $1.54 per share, delivering a surprise of 42.59%.
Price and EPS Surprise
For Hamilton Lane, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Hamilton Lane has an Earnings ESP of +0.35% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #3 (Hold), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on May 21, 2026.
Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
SAN DIEGO, April 28, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Hamilton Lane Incorporated (NASDAQ: HLNE). The investigation focuses on Hamilton Lane’s executive officers and whether investor losses may be recovered under federal securities laws.
What if I purchased Hamilton Lane securities?
If you purchased Hamilton Lane securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.
Or for more information, contact Jim Baker at [email protected] or (619) 814-4471. There is no cost or obligation to you.
Background of the investigation
On April 27, 2026, a report by Hunterbrook Media raised concerns regarding Hamilton Lane’s reported financial performance and underlying business metrics. Among other things, the report questioned the Company’s presentation of fee-related earnings (“FRE”), including the inclusion of performance-related revenues tied to unrealized gains and the exclusion of certain expenses, as well as the extent to which reported earnings growth reflected underlying economic performance.
The report also highlighted issues relating to fund flows and liquidity, including reported outflows in certain investment vehicles and the Company’s reliance on continued inflows and stable redemption activity. In addition, the report discussed valuation practices and the role of unrealized gains and transaction pricing in driving reported performance.
Following this disclosure, the price of Hamilton Lane’s stock declined approximately 6%, damaging investors.
In light of this disclosure, Johnson Fistel is investigating whether Hamilton Lane complied with the federal securities laws. If you suffered losses from your investment in Hamilton Lane stock, contact Johnson Fistel.
About Johnson Fistel, PLLP | Securities Fraud & Investor Rights
Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits and also assists foreign investors who purchased shares on U.S. exchanges. To learn more, visit www.johnsonfistel.com.
Achievements
In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, reflecting the firm’s effectiveness in advocating for investors and recovering approximately $90,725,000 for clients in cases where it served as lead or co-lead counsel.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
(619) 814-4471 | [email protected] | [email protected]
, /PRNewswire/ - Power Sustainable Energy Infrastructure ("PSEI"), the renewable energy infrastructure platform of Power Sustainable, today announced it completed the sale of a 49.9% interest in Big Sky Wind, a 240 MW operating wind facility located in Illinois, to funds managed by Hamilton Lane (Nasdaq: HLNE) and GCM Grosvenor, two leading global private markets investment firms. PSEI will retain a majority interest in the asset and continue to oversee its operations.
The transaction reflects PSEI's strategy of partnering with long-term institutional investors while actively recycling capital to fund new investments across its portfolio.
"We are pleased to partner with Hamilton Lane and GCM Grosvenor on Big Sky Wind," said Pierre-Olivier Perras, Managing Partner at PSEI. "This transaction highlights the quality of the asset and reflects our disciplined approach to active portfolio management and capital recycling, enabling us to reinvest in new opportunities and continue to scale our platform."
Taylor McManus, Principal, Infrastructure Investment Team at Hamilton Lane, said: "We are happy to be partnering with Power Sustainable, a proven investor and operator of renewable power generation across North America. This was a unique opportunity to invest in an operating wind asset with a strong contractual framework, an attractive risk return profile and favorable transaction dynamics."
"Big Sky Wind is a high-quality, repowered asset with a strong operating profile and exposure to a constructive U.S. power market," said Kevin Pellecchia, Executive Director, Infrastructure Investments at GCM Grosvenor. "Our investment reflects a focus on accessing established infrastructure assets alongside experienced sponsors, where we see the potential for durable cash flows and long-term value creation."
Big Sky Wind is an operating wind project with a strong performance track record, supported by high availability and stable cash flows. The asset, which was fully repowered in 2022, is located in the PJM market and is positioned to benefit from supportive market fundamentals.
This transaction underscores PSEI's ability to originate, scale, and optimize high-quality infrastructure assets, while maintaining a strong pipeline of investment opportunities across its core markets.
About Power Sustainable
Power Sustainable is a multi-platform alternative asset manager investing across the core sectors of the real economy as they undergo structural change. The firm allocates capital across energy, food, mobility, connectivity, and the built environment, investing selectively along their value chains through equity and credit strategies. Power Sustainable focuses on opportunities where transition, resilience, and resource efficiency are drivers of performance and risk. Power Sustainable is a subsidiary of Power Corporation of Canada (TSX: POW), an international management and holding company focused on financial services in North America, Europe, and Asia. Learn more on Power Sustainable's LinkedIn and Website.
About Hamilton Lane
Hamilton Lane (Nasdaq: HLNE) is one of the largest private markets investment firms globally, providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 780 professionals operating in offices throughout North America, Europe, Asia Pacific and the Middle East. Hamilton Lane has $1.0 trillion in assets under management and supervision, composed of $146.1 billion in discretionary assets and $871.5 billion in non-discretionary assets, as of December 31, 2025. Hamilton Lane specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors and geographies. For more information, please visit our website or follow us on LinkedIn.
About GCM Grosvenor
GCM Grosvenor (Nasdaq: GCMG) is a global alternative asset management solutions provider with approximately $91 billion in assets under management across private equity, infrastructure, real estate, credit, and absolute return investment strategies. The firm has specialized in alternatives for more than 50 years and is dedicated to delivering value for clients by leveraging its cross-asset class and flexible investment platform.
GCM Grosvenor's experienced team of approximately 550 professionals serves a global client base of institutional and individual investors. The firm is headquartered in Chicago, with offices in New York, Toronto, London, Frankfurt, Tokyo, Hong Kong, Seoul and Sydney. For more information, visit: gcmgrosvenor.com.
Wall Street expects a year-over-year increase in earnings on higher revenues when Hamilton Lane (HLNE - Free Report) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on May 21, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis private-market investment firm is expected to post quarterly earnings of $1.44 per share in its upcoming report, which represents a year-over-year change of +19%.
Revenues are expected to be $200.95 million, up 1.5% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.02% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Hamilton Lane?For Hamilton Lane, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.35%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Hamilton Lane will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Hamilton Lane would post earnings of $1.28 per share when it actually produced earnings of $1.55, delivering a surprise of +21.09%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Hamilton Lane appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Investors in Hamilton Lane Incorporated (HLNE - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the May 15, 2026 $55.00 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for Hamilton Lane shares, but what is the fundamental picture for the company? Currently, Hamilton Lane is a Zacks Rank #3 (Hold) in the Financial - Investment Management industry that ranks in the Bottom 19% of our Zacks Industry Rank. Over the last 60 days, our Zacks Consensus Estimate for the current quarter has moved from $1.48 per share to $1.46 in that period.
Given the way analysts feel about Hamilton Lane right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
In its upcoming report, Hamilton Lane (HLNE - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.44 per share, reflecting an increase of 19% compared to the same period last year. Revenues are forecasted to be $200.95 million, representing a year-over-year increase of 1.5%.
The consensus EPS estimate for the quarter has undergone a downward revision of 2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Hamilton Lane metrics that are routinely monitored and predicted by Wall Street analysts.
Based on the collective assessment of analysts, 'Revenues- Incentive fees' should arrive at $46.07 million. The estimate points to a change of -34.3% from the year-ago quarter.
Analysts' assessment points toward 'Revenues- Management and advisory fees- Customized separate accounts' reaching $36.25 million. The estimate indicates a change of +12.4% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenues- Management and advisory fees' will likely reach $154.88 million. The estimate suggests a change of +21.2% year over year.
Analysts forecast 'Revenues- Management and advisory fees- Specialized funds' to reach $101.34 million. The estimate indicates a year-over-year change of +27.7%.
It is projected by analysts that the 'Fee Earning AUM - Customized Separate Accounts (CSA)' will reach $41.64 billion. The estimate compares to the year-ago value of $39.34 billion.
The consensus among analysts is that 'Fee Earning AUM - Total' will reach $81.17 billion. The estimate is in contrast to the year-ago figure of $72.05 billion.
Analysts predict that the 'Fee Earning AUM - Specialized Funds (SF)' will reach $39.54 billion. The estimate is in contrast to the year-ago figure of $32.70 billion.
According to the collective judgment of analysts, 'Total AUM & AUA' should come in at $1014.21 billion. The estimate is in contrast to the year-ago figure of $957.77 billion.
The consensus estimate for 'Assets Under Management (AUM)' stands at $144.88 billion. The estimate is in contrast to the year-ago figure of $138.30 billion.
The collective assessment of analysts points to an estimated 'Assets Under Advisement (AUA)' of $869.33 billion. Compared to the present estimate, the company reported $819.47 billion in the same quarter last year.
View all Key Company Metrics for Hamilton Lane here>>>
Hamilton Lane shares have witnessed a change of -20.3% in the past month, in contrast to the Zacks S&P 500 composite's +5.6% move. With a Zacks Rank #3 (Hold), HLNE is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
— Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and advances its next phase of growth —
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company’s executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio.
David’s appointment reflects Cosette’s continued investment in the commercial capabilities required to support the next level of growth,” said Apurva Saraf, President and CEO of Cosette Pharmaceuticals.
Share In this new role, David will oversee all branded commercial functions – including sales, marketing, market access, commercial operations, analytics, and portfolio strategy. He will be responsible for driving performance across Cosette’s marketed portfolio of 21 brands, supporting the integration and growth of acquired assets, and ensuring strong alignment between commercial execution and the company’s broader strategic and financial objectives.
“David’s appointment reflects Cosette’s continued investment in the commercial capabilities required to support the next level of growth,” said Apurva Saraf, President and CEO of Cosette Pharmaceuticals. “His deep expertise in commercial strategy, market access, portfolio management, and P&L leadership will be valuable as we continue to strengthen our branded portfolio and integrate new assets.”
David brings more than 25 years of commercial and enterprise leadership experience across oncology, rare disease and gene therapy in specialty pharmaceuticals markets. Most recently, David served as Vice President, Business Unit Head, US Oncology at Ferring Pharmaceuticals, where he held full U.S. P&L ownership responsibility. He also previously served as Franchise General Manager at Melinta Therapeutics and spent 17 years at Merck & Co. / Schering-Plough in progressive global, U.S., and regional commercial leadership roles.
“I am proud to join Cosette, an organization that has built a differentiated platform with brands that help patients live better lives,” David shared. “I am excited to join a leadership team that will take Cosette’s branded portfolio to the next phase of corporate growth by maximizing current and acquired assets, expanding patient access to important medicines, and alleviating the burden and suffering of patients and their families.”
David earned his Master of Business Administration and Bachelor of Science in Finance from Seton Hall University’s W. Paul Stillman School of Business. He also served as a board member of Enhanced HealthCare Solutions.
About Cosette Pharmaceuticals
Cosette Pharmaceuticals, Inc. is a U.S.-based, leading specialty pharmaceutical company providing some of the most trusted and well-known brands in medicine — developing and delivering products that make a difference in patients’ lives. Cosette’s strong growth has been driven by its best-in-class marketing, promotion, and strategic distribution capabilities, enabling the company to scale efficiently while continuing to invest in high-quality, patient-centered therapies. Cosette has corporate headquarters in Bridgewater, New Jersey and is supported by 350+ dedicated team members across all functional areas. Cosette is backed by Avista Healthcare Partners, a healthcare focused private equity firm, and funds managed by Hamilton Lane, a private markets investment management firm (Nasdaq: HLNE). For more information, please visit www.cosettepharma.com or follow Cosette on LinkedIn.
On May 19, 2026, Hamilton Lane Inc (HLNE) shares fell 3.0%, closing at $84.11. The stock has been under pressure, trading within a 52-week range of $84.05 to $1
, /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) today reported its results for the fourth quarter and full fiscal year ended March 31, 2026.
The Company issued a full detailed presentation of its fourth quarter and full fiscal year 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/.
Dividend
Hamilton Lane has declared a quarterly dividend of $0.60 per share of Class A common stock to record holders at the close of business on June 18, 2026 that will be paid on July 7, 2026. The target full-year dividend of $2.40 represents a 11% increase from the prior fiscal year dividend.
Stock Repurchase Plan
Hamilton Lane announced today that its board of directors approved an increase in the authorization under the Company's existing stock repurchase program to $100 million of its Class A common stock, net of amounts already repurchased under the prior authorization, with no share count or duration limitations.
Conference Call
Hamilton Lane will discuss fourth quarter and full fiscal year 2026 results in a webcast and conference call today, Thursday, May 21, 2026, at 11:00 a.m. Eastern Time.
For access to the live event via the webcast, visit Hamilton Lane's Shareholders website (https://shareholders.hamiltonlane.com/) at least 15 minutes prior to the start of the call. This feature will be in listen-only mode.
A replay of the webcast will be available approximately two hours after the live broadcast for a period of one year and can be accessed in the same manner as the live webcast at the Shareholders page of Hamilton Lane's website.
About Hamilton Lane
Hamilton Lane (Nasdaq: HLNE) is one of the largest private markets investment firms globally, providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 785 professionals operating in offices throughout North America, Europe, Asia Pacific and the Middle East. Hamilton Lane has $1 trillion in assets under management and supervision, composed of $141.8 billion in discretionary assets and $905.3 billion in non-discretionary assets, as of March 31, 2026. Hamilton Lane specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors and geographies. For more information, please visit http://www.hamiltonlane.comor follow Hamilton Lane on LinkedIn: https://www.linkedin.com/company/hamilton-lane/.
Forward-Looking Statements
Some of the statements in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Words such as "will," "expect," "believe," "estimate," "continue," "anticipate," "intend," "plan" and similar expressions, or the negative version of these words or other comparable words, are intended to identify these forward-looking statements. Forward-looking statements discuss management's current expectations and projections relating to our financial position, results of operations, plans, objectives, future performance and business. All forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause actual results to be materially different, including, risks relating to: the historical performance of our investments may not be indicative of future results or future returns on our Class A common stock; our ability to identify suitable investment opportunities for our clients; the impact of any poorly performing investments on our investment management revenue and earnings as well as our ability to raise capital; intense competition in our industry, including competition for access to investments and for customized separate account and advisory clients; customized separate account and advisory account fee revenue not being a long-term contracted source of revenue; our ability to appropriately deal with conflicts of interest; our ability to retain our senior management team and attract additional qualified investment professionals; our ability to expand our business and formulate new business strategies; the impact of declines in the pace or size of fundraising or investments made by us on behalf of our specialized funds or customized separate accounts; our ability to manage our obligations under our debt agreements and the dependence on leverage by certain funds, customized separate accounts and portfolio companies; our ability to comply with the investment guidelines set by our clients; the impact of misconduct by our employees, advisors or third-party service providers; the unpredictable and sporadic timing at which we receive carried interest distributions; the exercise of redemption or repurchase rights by investors in certain of our funds; the subjectivity of valuation methodologies; our investments may be in relatively high-risk, illiquid assets; extensive government regulation, compliance failures and changes in law or regulation could adversely affect us; our ability to maintain our desired fee structure; failure to maintain the security of our information technology networks, or those of our third-party service providers, or data security breaches; volatile market, economic and geopolitical conditions or catastrophic events, which can adversely affect our fundraising, our business and the investments made by our funds or accounts; and our only material asset is our interest in Hamilton Lane Advisors, L.L.C., and we are accordingly dependent upon distributions from such entity to pay dividends, taxes and other expenses.
The foregoing list of factors is not exhaustive and should be read in conjunction with the other cautionary statements that are included in our filings with the Securities and Exchange Commission. For more information regarding these risks and uncertainties as well as additional risks we face, you should refer to the "Risk Factors" detailed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 and in our subsequent reports filed from time to time with the Securities and Exchange Commission, including our upcoming Annual Report on Form 10-K for fiscal 2026. The forward-looking statements included in this release are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information or future events, except as otherwise required by law.
Hamilton Lane (HLNE - Free Report) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.21 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +4.20%. A quarter ago, it was expected that this private-market investment firm would post earnings of $1.28 per share when it actually produced earnings of $1.55, delivering a surprise of +21.09%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Hamilton Lane, which belongs to the Zacks Financial - Investment Management industry, posted revenues of $193.57 million for the quarter ended March 2026, missing the Zacks Consensus Estimate by 3.56%. This compares to year-ago revenues of $197.97 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Hamilton Lane shares have lost about 36.6% since the beginning of the year versus the S&P 500's gain of 8.6%.
What's Next for Hamilton Lane?While Hamilton Lane has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Hamilton Lane was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.39 on $210.95 million in revenues for the coming quarter and $6.39 on $914.23 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Financial - Investment Management is currently in the bottom 16% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Sound Point Meridian Capital, Inc. (SPMC - Free Report) , is yet to report results for the quarter ended March 2026. The results are expected to be released on May 27.
This company is expected to post quarterly earnings of $0.41 per share in its upcoming report, which represents a year-over-year change of -37.9%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Sound Point Meridian Capital, Inc.'s revenues are expected to be $17.2 million, down 24.1% from the year-ago quarter.
For the quarter ended March 2026, Hamilton Lane (HLNE - Free Report) reported revenue of $193.57 million, down 2.2% over the same period last year. EPS came in at $1.49, compared to $1.21 in the year-ago quarter.
The reported revenue represents a surprise of -3.56% over the Zacks Consensus Estimate of $200.7 million. With the consensus EPS estimate being $1.43, the EPS surprise was +4.2%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Hamilton Lane performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Fee Earning AUM - Customized Separate Accounts (CSA): $40.94 billion compared to the $41.64 billion average estimate based on three analysts.Fee Earning AUM - Total: $81.51 billion versus $81.07 billion estimated by three analysts on average.Fee Earning AUM - Specialized Funds (SF): $40.57 billion compared to the $39.44 billion average estimate based on three analysts.Total AUM & AUA: $1047.15 billion versus $1014.21 billion estimated by two analysts on average.Assets Under Management (AUM): $141.83 billion compared to the $144.88 billion average estimate based on two analysts.Assets Under Advisement (AUA): $905.32 billion versus the two-analyst average estimate of $869.33 billion.Revenues- Incentive fees: $38.39 million versus the three-analyst average estimate of $46.07 million. The reported number represents a year-over-year change of -45.3%.Revenues- Management and advisory fees- Customized separate accounts: $35.08 million versus $36.25 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +8.7% change.Revenues- Management and advisory fees: $155.22 million compared to the $154.63 million average estimate based on three analysts. The reported number represents a change of +21.4% year over year.Revenues- Management and advisory fees- Specialized funds: $103.27 million versus $101.09 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +30.2% change.Revenues- Management and advisory fees- Fund reimbursement revenue: $2.43 million versus $1.5 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +20.2% change.Revenues- Management and advisory fees- Distribution management: $0.29 million compared to the $1.4 million average estimate based on two analysts. The reported number represents a change of -59% year over year.View all Key Company Metrics for Hamilton Lane here>>>
Shares of Hamilton Lane have returned -19.7% over the past month versus the Zacks S&P 500 composite's +4.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Stock Rotation is Underway: Here are the Winners Moving ForwardHamilton Lane NASDAQ: HLNE reported higher fiscal 2026 revenue and earnings growth, while management used the company’s fiscal fourth-quarter earnings call to push back against concerns about private markets and highlight momentum in its evergreen fund platform.
John Oh, Hamilton Lane’s head of shareholder relations, said the firm ended fiscal 2026 with a total asset footprint of $1 trillion, up 9% year over year. Assets under management were $142 billion, up $4 billion, or 3%, from the prior year, while assets under advisement reached $905 billion, up more than $86 billion, or 10%.
Get Hamilton Lane alerts:
Total management and advisory fees for the year were $584 million, up 14% from fiscal 2025. Total fee-related revenue, which includes management fees and fee-related performance revenue, rose 20% to $687 million. Fee-related earnings increased 25% to $345 million.
The company reported fiscal 2026 GAAP earnings per share of $5.92, based on $249 million of GAAP net income. Non-GAAP earnings per share were $5.90, based on $321 million of adjusted net income.
Oh also said Hamilton Lane’s board approved an 11% increase in the company’s annual fiscal dividend to $2.40 per share, or $0.60 per share per quarter. He said the increase marked the ninth consecutive annual double-digit percentage dividend increase since the firm went public in 2017.
Management Says Private Markets Are Improving Co-Chief Executive Officer Erik Hirsch said industry headlines have overstated concerns about private markets, arguing that Hamilton Lane’s data show a healthier environment emerging across several asset classes.
Hirsch said private equity is moving from a slower period into a better dealmaking and exit environment. He cited global buyout deal volume rising more than 40% in 2025 and total exit value increasing nearly 50%, which he described as the second-best year on record and close to the 2021 peak.
He also said private credit fundamentals remain solid, pointing to disciplined leverage, “benign” defaults and attractive spreads over public loans. Hirsch said equity contributions averaged about 50% in 2025 compared with about 33% in 2007, and said the default rate remains below 2%.
Hirsch highlighted venture and growth equity as a way to access artificial intelligence, data infrastructure, defense innovation and next-generation software opportunities, many of which he said are still developing in private markets. He also said secondaries, infrastructure and real estate continue to offer opportunities, while emphasizing that manager selection remains critical because performance dispersion across private-market strategies is wide and persistent.
Evergreen Funds Remain a Key Growth Driver Hamilton Lane ended the fiscal year with $82 billion of fee-earning AUM, up $9 billion, or 13%, from the prior year. Hirsch said growth continued to be driven largely by specialized funds, particularly evergreen products. Specialized fund fee-earning AUM ended fiscal 2026 at $41 billion, up $8 billion, or 24%, over the last 12 months.
Hirsch said Hamilton Lane’s evergreen platform produced more than $1 billion of net inflows during the quarter, despite what he described as a difficult industry backdrop for evergreen funds in calendar first quarter, especially in private credit. He said no Hamilton Lane evergreen fund had to impose gates, and no individual evergreen fund ended the quarter in a net outflow position.
Total evergreen AUM ended the quarter at more than $17.5 billion, representing 64% year-over-year growth. Hirsch said January and February were strong months, with net subscriptions of $471 million and $591 million, respectively. March turned slightly negative, with $17 million of net outflows, as gross redemptions increased and gross sales slowed.
For April, Hirsch said the company expected more than $265 million in aggregate net inflows across the evergreen product suite. In response to an analyst question from KBW’s Alex Bond, Hirsch said he would be “very disappointed” if April became the new run-rate reference point, adding that the company’s goal is to return to and exceed January and February levels.
Hirsch said institutional investors now represent more than 25% of capital flowing into Hamilton Lane’s evergreen products. He cited allocations from pensions, insurance companies, family offices and other institutional clients, including a private credit mandate from a large U.S. public pension plan. Part of that mandate seeded Hamilton Lane’s new U.S. Credit Evergreen interval fund, while the rest was deployed in a separate account.
In April, Hamilton Lane launched the Hamilton Lane Credit Income Fund, its 12th evergreen fund and its first daily subscription and daily priced offering. Hirsch said the fund focuses on senior private credit and launched with nearly $325 million committed by seed investors, including public pension plans, multi-employer union retirement pension plans and Hamilton Lane’s balance sheet capital.
Secondaries Strategy and Fundraising in Focus Hirsch spent a significant portion of the call discussing the secondaries market, where investors buy and sell existing private-market fund interests. He said secondary transactions often occur at discounts to net asset value because sellers are seeking liquidity in an illiquid market, but argued those transaction prices do not determine the value of the underlying assets.
Hirsch said Hamilton Lane committed nearly $5.5 billion to secondaries in calendar 2025 while turning down nearly 99% of the total dollar deal flow it reviewed. In response to UBS analyst Michael Brown, Hirsch said that selectivity was not primarily about competition but about asset quality, manager quality and price.
Hamilton Lane has launched fundraising for its seventh secondary fund and second venture product, and Hirsch said initial closes for both are expected in the coming months. The company has also launched fundraising for its first GP-led secondary fund, with a first close expected before the end of calendar 2026.
Hirsch also updated investors on the firm’s sixth Equity Opportunities Fund, which focuses on direct equity investments alongside general partners. The fund has raised about $2.8 billion after additional closes through the first half of May, more than 35% larger than the prior vintage, he said.
CFO Details Revenue, Expenses and Buybacks Chief Financial Officer Jeff Armbrister said management and advisory fees increased 14% for fiscal 2026 despite lower retroactive fees. Hamilton Lane received $3 million in retro fees in fiscal 2026, compared with nearly $21 million in fiscal 2025.
Specialized revenue increased $59 million, or 19%, driven primarily by a $7 billion increase in fee-earning AUM in the evergreen platform and more than $1 billion raised in the latest direct equity fund during fiscal 2026. Customized separate account revenue increased $7 million, or 5%, due to new accounts, client re-ups and continued investment activity.
Revenue from reporting, monitoring, data and analytics offerings increased by about $7 million, or 22%, as the company continued to grow its technology solutions business. Incentive fees totaled $175 million for the period, including fee-related performance revenue primarily from quarterly crystallization of performance fees for the U.S. Private Assets Evergreen Fund.
Armbrister said total expenses increased $38 million from the prior year. Compensation and benefits rose $25 million, mainly because of higher headcount and equity-based compensation. General and administrative expenses increased $13 million, driven largely by revenue-related expenses such as third-party commissions and platform fees tied to the U.S. evergreen product.
Fee-related earnings margin was 50% for fiscal 2026, up from 48% in the prior year. Armbrister said both fee-related earnings and margin benefited from fee-related performance revenue and management fee growth.
The company repurchased 199,000 shares during the quarter at a weighted average price of $100.43, spending about $20 million. Armbrister said the board increased Hamilton Lane’s repurchase authorization to allow up to $100 million of Class A common stock repurchases, less the approximately $20 million already spent, leaving about $80 million available.
Wealth Distribution and Liquidity Discussed in Q&A Analysts asked several questions about Hamilton Lane’s wealth distribution strategy and evergreen liquidity. In response to JPMorgan analyst Ken Worthington, Hirsch said several products are approaching what he views as “critical mass” of $1 billion or more, and the firm is in active dialogue with distribution partners.
Hirsch said Hamilton Lane has made several senior hires on the wealth side, generally from larger asset management firms, but added that the company has not yet seen much benefit from those hires because they are still being onboarded.
Asked by Morgan Stanley analyst Michael Cyprys about liquidity management in evergreen funds, Hirsch said the vehicles generate distributions and cash liquidity, maintain cash reserves and have lines of credit in place. He said the portfolios are highly diversified and that the firm continually models liquidity needs.
Hirsch closed the call by thanking investors and analysts for their engagement and support.
About Hamilton Lane NASDAQ: HLNEHamilton Lane is a global private markets investment management firm specializing in the full spectrum of private equity and credit strategies. The company partners with institutional investors and wealth managers to design, implement and manage customized portfolios in primary fund investing, secondary market transactions and direct co-investment opportunities. By combining investment selection, portfolio construction and ongoing monitoring, Hamilton Lane seeks to optimize risk-adjusted returns across diverse private markets exposures.
Founded in 1991, Hamilton Lane has developed a track record of investment and advisory services in private markets.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Hamilton Lane Right Now?Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
On May 21, 2026, Hamilton Lane Inc (HLNE) shares rose 4.1% to a current price of $88.49. The stock has experienced significant volatility over the past year, tr
Hamilton Lane Inc (NASDAQ:HLNE) reported mixed results for the fourth quarter on Thursday.
The company posted quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.43 per share. The company reported quarterly sales of $193.566 million which missed the analyst consensus estimate of $203.058 million.
Hamilton Lane shares rose 1.9% to trade at $90.25 on Friday.
These analysts made changes to their price targets on Hamilton Lane following earnings announcement.
BMO Capital analyst Brennan Hawken maintained the stock with an Outperform rating and lowered the price target from $108 to $102. Oppenheimer analyst Chris Kotowski maintained the stock with an Outperform rating and raised the price target from $171 to $179. Considering buying HLNE stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Hamilton Lane says critics misunderstand how private-equity fund stakes are valued, defending the industry’s practice of booking gains on discounted secondary-market purchases. (Courtesy Hamilton Lane)
Private asset manager Hamilton Lane reported its fiscal year results last week, and fee earnings grew 25%. Yet the firm’s stock is down 36% since December, while the S&P 500 has risen 9%.
LOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hercules Capital, Inc. (“Hercules” or “the Company”) (NYSE: HTGC) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company’s securities between May 1, 2025 and February 27, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before May 19, 2026.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Hercules misled investors about the due diligence it performed during the loan origination process. The Company overstated the due diligence of its portfolio valuation process. The Company misclassified portfolio investments. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Hercules, investors suffered damages.
Join the case to recover your losses
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335 [email protected]
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hercules Capital, Inc. (NYSE: HTGC) between May 1, 2025 and February 27, 2026, inclusive (the “Class Period”), of the important May 19, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Hercules Capital securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Hercules Capital class action, go to https://rosenlegal.com/submit-form/?case_id=56968 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 19, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Hercules Capital overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) Hercules Capital overstated the due diligence with which it conducted its portfolio valuation process; (3) Hercules Capital reported misclassified portfolio investments; (4) as a result of the foregoing, Hercules Capital overstated and/or misrepresented its portfolio valuations; and (5) as a result of the foregoing, defendants’ positive statements about Hercules Capital’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Hercules Capital class action, go to https://rosenlegal.com/submit-form/?case_id=56968 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
LOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 19, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Hercules Capital, Inc. (“Hercules Capital” or the “Company”) (NYSE: HTGC) securities between May 1, 2025 and February 27, 2026, inclusive (the “Class Period”).
IF YOU SUFFERED A LOSS ON YOUR HERCULES INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
What Happened?
On February 27, 2026, Hunterbrook Media published a report stating that, “according to a former Hercules analyst who worked on deal sourcing” the Company’s process for deal sourcing essentially amounted to “[g]o[ing] on the website for Google Ventures and just see what they invest in and just copy it.” The report stated, according to a former employee, deal sourcing managers “don’t want anything else,” and essentially just rely on other investors to have done due diligence, instead of doing their own.
The report continued, revealing that, “once Hercules makes the loans, the valuation process itself may warrant scrutiny,” as “[a] former member of Hercules’ finance team described a small, overstretched team with few checks in place.” The report revealed the valuations team “consisted of just four people in a single reporting line responsible for dozens of companies,” with “few checks or cross-team review.”
The report also alleged that Hercules Capital underrepresents its significant software debt exposure in part, by “assign[ing] certain businesses that describe themselves as software companies to categories outside of software.” The report also cast doubt on to the Company’s book value, which marks its software debt “at 100 cents on the dollar” despite “billions worth of [software] debt across the industry falling into distressed territory.”
On this news, Hercules Capital’s stock price fell $1.22, or 7.9%, to close at $14.21 per share on February 27, 2026, on unusually heavy trading volume.
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) the Company overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) the Company overstated the due diligence with which it conducted its portfolio valuation process; (3) the Company reported misclassified portfolio investments; (4) as a result of the foregoing, the Company overstated and/or misrepresented its portfolio valuations; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you purchased or otherwise acquired Hercules Capital securities during the Class Period, you may move the Court no later than May 19, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles H. Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hercules Capital (HTGC) To Contact Him Directly To Discuss Their Options
If you purchased or acquired Hercules Capital securities between May 1, 2025 and February 27, 2026, and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) --
What’s Happening?
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Hercules Capital, Inc. (“Hercules Capital” or the “Company”) (NYSE:HTGC) in the The United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Hercules Capital securities between May 1, 2025 and February 27, 2026, both dates inclusive (the “Class Period”).Investors have until May 19, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit. What are the Allegation Details?
According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Hercules Capital overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) Hercules Capital overstated the due diligence with which it conducted its portfolio valuation process; (3) Hercules Capital reported misclassified portfolio investments; (4) as a result of the foregoing, Hercules Capital overstated and/or misrepresented its portfolio valuations; and (5) as a result of the foregoing, defendants’ positive statements about Hercules Capital’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. What are the Next Steps?
If you purchased or otherwise acquired Hercules Capital shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hercules Capital, Inc. (NYSE: HTGC) between May 1, 2025 and February 27, 2026, inclusive (the "Class Period"), of the important May 19, 2026 lead plaintiff deadline.
So what: If you purchased Hercules Capital securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the Hercules Capital class action, go to https://rosenlegal.com/submit-form/?case_id=56968 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 19, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Hercules Capital overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) Hercules Capital overstated the due diligence with which it conducted its portfolio valuation process; (3) Hercules Capital reported misclassified portfolio investments; (4) as a result of the foregoing, Hercules Capital overstated and/or misrepresented its portfolio valuations; and (5) as a result of the foregoing, defendants' positive statements about Hercules Capital's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Hercules Capital class action, go to https://rosenlegal.com/submit-form/?case_id=56968 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hercules Capital To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Hercules Capital between May 1, 2025 and February 27, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - May 18, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hercules Capital, Inc. ("Hercules Capital" or the "Company") (NYSE: HTGC) and reminds investors of the May 19, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) the Company overstated the due diligence with which it conducted its portfolio valuation process; (3) the Company reported misclassified portfolio investments; (4) as a result of the foregoing, the Company overstated and/or misrepresented its portfolio valuations; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On February 27, 2026, Hunterbrook Media published a report stating that, "according to a former Hercules analyst who worked on deal sourcing" the Company's process for deal sourcing essentially amounted to "[g]o[ing] on the website for Google Ventures and just see what they invest in and just copy it." The report stated, according to a former employee, deal sourcing managers "don't want anything else," and essentially just rely on other investors to have done due diligence, instead of doing their own.
The report continued, revealing that, "once Hercules makes the loans, the valuation process itself may warrant scrutiny," as "[a] former member of Hercules' finance team described a small, overstretched team with few checks in place." The report revealed the valuations team "consisted of just four people in a single reporting line responsible for dozens of companies," with "few checks or cross-team review."
The report also alleged that Hercules Capital underrepresents its significant software debt exposure in part, by "assign[ing] certain businesses that describe themselves as software companies to categories outside of software." The report also cast doubt on to the Company's book value, which marks its software debt "at 100 cents on the dollar" despite "billions worth of [software] debt across the industry falling into distressed territory."
On this news, Hercules Capital's stock price fell $1.22, or 7.9%, to close at $14.21 per share on February 27, 2026, on unusually heavy trading volume.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Hercules Capital's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Hercules Capital class action, go to www.faruqilaw.com/HTGC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297835
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
, /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hercules Capital, Inc. (NYSE: HTGC).
Shareholders who purchased shares of HTGC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Company overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) the Company overstated the due diligence with which it conducted its portfolio valuation process; (3) the Company reported misclassified portfolio investments; (4) as a result of the foregoing, the Company overstated and/or misrepresented its portfolio valuations; and (5) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
DEADLINE: May 19, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/hercules-capital-inc-loss-submission-form/?id=186487&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HTGC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is May 19, 2026. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903
LOS ANGELES, May 19, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hercules Capital, Inc., (“Hercules” or the "Company") (NYSE: HTGC) investors of a class action on behalf of investors that bought securities between May 1, 2025 and January 27, 2026, inclusive (the “Class Period”). Hercules investors have until May 21, 2026 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or join the case via https://portnoylaw.com/hercules-capital-inc. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On February 27, 2026, Hunterbrook Media published a report stating that, “according to a former Hercules analyst who worked on deal sourcing” the Company’s process for deal sourcing essentially amounted to “[g]o[ing] on the website for Google Ventures and just see what they invest in and just copy it.” The report stated, according to a former employee, deal sourcing managers “don’t want anything else,” and essentially just rely on other investors to have done due diligence, instead of doing their own.
The report continued, revealing that, “once Hercules makes the loans, the valuation process itself may warrant scrutiny,” as “[a] former member of Hercules’ finance team described a small, overstretched team with few checks in place.” The report revealed the valuations team “consisted of just four people in a single reporting line responsible for dozens of companies,” with “few checks or cross-team review.”
The report also alleged that Hercules Capital underrepresents its significant software debt exposure in part, by “assign[ing] certain businesses that describe themselves as software companies to categories outside of software.” The report also cast doubt on to the Company’s book value, which marks its software debt “at 100 cents on the dollar” despite “billions worth of [software] debt across the industry falling into distressed territory.”
On this news, Hercules Capital’s stock price fell $1.22, or 7.9%, to close at $14.21 per share on February 27, 2026, on unusually heavy trading volume.
The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar [email protected]
310-692-8883
www.portnoylaw.com
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hercules Capital To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Hercules Capital between May 1, 2025 and February 27, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hercules Capital, Inc. (“Hercules Capital” or the “Company”) (NYSE: HTGC) and reminds investors of the May 19, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) the Company overstated the due diligence with which it conducted its portfolio valuation process; (3) the Company reported misclassified portfolio investments; (4) as a result of the foregoing, the Company overstated and/or misrepresented its portfolio valuations; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On February 27, 2026, Hunterbrook Media published a report stating that, “according to a former Hercules analyst who worked on deal sourcing” the Company’s process for deal sourcing essentially amounted to “[g]o[ing] on the website for Google Ventures and just see what they invest in and just copy it.” The report stated, according to a former employee, deal sourcing managers “don’t want anything else,” and essentially just rely on other investors to have done due diligence, instead of doing their own.
The report continued, revealing that, “once Hercules makes the loans, the valuation process itself may warrant scrutiny,” as “[a] former member of Hercules’ finance team described a small, overstretched team with few checks in place.” The report revealed the valuations team “consisted of just four people in a single reporting line responsible for dozens of companies,” with “few checks or cross-team review.”
The report also alleged that Hercules Capital underrepresents its significant software debt exposure in part, by “assign[ing] certain businesses that describe themselves as software companies to categories outside of software.” The report also cast doubt on to the Company’s book value, which marks its software debt “at 100 cents on the dollar” despite “billions worth of [software] debt across the industry falling into distressed territory.”
On this news, Hercules Capital’s stock price fell $1.22, or 7.9%, to close at $14.21 per share on February 27, 2026, on unusually heavy trading volume.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Hercules Capital’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Hercules Capital class action, go to www.faruqilaw.com/HTGC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Hercules Capital Inc. (NYSE: HTGC). The investigation concerns whether certain officers and directors of Hercules Capital breached their fiduciary duties owed to the Company.
If you purchased Hercules Capital Inc. (NYSE: HTGC) shares prior to May 1, 2025, and continue to hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/hercules-shareholder-investigation/, contact Joshua H. Grabar at [email protected], or call 267-507-6085. You may be able to seek corporate governance reforms, the return of funds back to the Company, and a court-approved incentive award at no cost to you whatsoever.
WHY? According to a recently filed federal securities fraud class action complaint, Hercules Capital Inc. (NYSE: HTGC), through certain of its officers, made materially false and misleading statements or failed to disclose that: (1) Hercules Capital overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) Hercules Capital overstated the due diligence with which it conducted its portfolio valuation process; (3) Hercules Capital reported misclassified portfolio investments; (4) as a result of the foregoing, Hercules Capital overstated and/or misrepresented its portfolio valuations; and (5) as a result of the foregoing, defendants' positive statements about Hercules Capital's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
WHAT CAN YOU DO NOW? If you purchased Hercules Capital Inc. (NYSE: HTGC) shares prior to May 1, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the Company, and a court-approved incentive award at no cost to you whatsoever. For more information, please visit https://grabarlaw.com/the-latest/hercules-shareholder-investigation/, contact Joshua H. Grabar at [email protected], or call 267-507-6085.
$HTGC #HTGC #HerculesCapital
LKQ CORPORATION (NASDAQ: LKQ):
WHAT IS HAPPENING? Grabar Law Office is investigating potential claims on behalf of investors of LKQ Corporation (NASDAQ: LKQ). The investigation concerns whether certain officers of the company have breached their fiduciary duties they owed to the company.
If you purchased LKQ Corporation (NASDAQ: LKQ) shares prior to February 27, 2023, and still hold shares today, you should visit https://grabarlaw.com/the-latest/lkq-shareholder-investigation/, contact Joshua H. Grabar at [email protected], or call 267-507-6085. You can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever.
WHY? A recently filed federal securities class action alleges that LKQ Corporation (NASDAQ: LKQ), through certain of its senior executives, misled investors regarding the performance and risks associated with its $2.1 billion acquisition of Uni-Select, including the FinishMaster business. According to the securities fraud complaint, LKQ Corporation, through certain of its officers, made materially false and misleading statements and failed to disclose that: (1) FinishMaster was losing major customers even before the acquisition closed; (2) the business was unable to maintain market share amid increasing competition; (3) integration efforts were not producing the expected revenue or margin benefits; and (4) competitive pricing pressure was eroding profitability. As a result, it is alleged that LKQ’s reported financial strength and growth prospects were materially overstated. Investors only began to learn the truth through a series of disclosures between April 2024 and July 2025, when LKQ cut financial guidance multiple times; reported missed revenue and margin targets; admitted that FinishMaster had been losing customers since before the acquisition; and disclosed ongoing market share losses due to competitive pricing pressure.
WHAT CAN YOU DO NOW? If you have held LKQ Corporation (NASDAQ: LKQ) shares since prior to February 27, 2023, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever. Visit https://grabarlaw.com/the-latest/lkq-shareholder-investigation/, contact Joshua H. Grabar at [email protected], or call 267-507-6085 to learn more. $LKQ #LKQ #LKQCorporation
NEW ERA ENERGY & DIGITAL, INC. (NASDAQ: NUAI):
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of New Era Energy & Digital, Inc. (NASDAQ: NUAI). The investigation concerns whether New Era and certain of its officers and directors breached their fiduciary duties owed to the Company.
If you purchased New Era Energy & Digital, Inc. (NASDAQ: NUAI) shares on or near the Company’s November 6, 2024 IPO, and still hold shares today, please visit https://grabarlaw.com/the-latest/newera-shareholder-investigation-2/ contact Joshua H. Grabar at [email protected], or call 267-507-6085. You may be able to seek corporate governance reforms, the return of funds back to the Company, and a court-approved incentive award at no cost to you whatsoever.
WHY? According to a recently filed federal securities fraud class action complaint, New Era (NASDAQ: NUAI) and certain of its officers allegedly made false and misleading statements concerning the Company’s Texas Critical Data Centers project, permitting progress, environmental liabilities, and related-party oil and gas transactions. The complaint alleges that New Era overstated its progress in obtaining regulatory permits and advancing its purported flagship Texas Critical Data Centers project, while publicly touting “tangible progress across all fronts including engineering, permitting, regulatory filings, and land expansion.” According to the complaint, the Company also represented to investors that it was making substantial progress toward a large-scale AI and high-performance computing data center campus in West Texas.
On December 12, 2025, however, Fuzzy Panda Research published a report alleging that New Era’s AI pivot was largely a “fantasy,” and that despite Company representations regarding permitting progress, “no applications have even been submitted” for required construction and environmental permits. The same report further alleged that a substantial number of New Era’s gas wells had been acquired from bankrupt entities tied to Company insiders and accused management of engaging in financial practices designed to enrich insiders while avoiding environmental cleanup obligations. On this news, New Era stock fell approximately 6.9% on December 12, 2025.
Then, on December 29, 2025, reports emerged that the New Mexico Attorney General had filed suit against New Era, its subsidiary Solis Partners, LLC, and Company CEO Everett Willard Gray II, alleging a “fraudulent oil-and-gas scheme” involving self-dealing transactions, shell entities, and strategic bankruptcies designed to evade plugging and remediation obligations for inactive wells. According to the complaint, the alleged scheme involved transferring wells among affiliated entities while leaving environmental liabilities behind in bankruptcy proceedings. On this news, New Era stock fell an additional 41%, closing at $2.69 per share on December 29, 2025.
WHAT CAN YOU DO NOW? If you purchased or otherwise acquired New Era Energy & Digital, Inc. (NASDAQ: NUAI) shares prior to November 6, 2024, and continue to hold shares today, you may have standing to seek corporate governance reforms, the return of funds back to the Company, and a court-approved incentive award at no cost to you whatsoever. Visit https://grabarlaw.com/the-latest/newera-shareholder-investigation-2/, email Joshua Grabar at [email protected], or call us at 267-507-6085.
#NewEraEnergy #NUAI $NUAI
POWER SOLUTIONS INTERNATIONAL, INC. (NASDAQ: PSIX):
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Power Solutions International, Inc. (NASDAQ: PSIX). The investigation concerns whether Power Solutions and certain of its executives breached their fiduciary duties.
If you purchased Power Solutions International, Inc. (NASDAQ: PSIX) shares prior to May 8, 2025, please visit https://grabarlaw.com/the-latest/psix-shareholder-investigation/, contact Joshua H. Grabar at [email protected], or call 267-507-6085. You can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever.
WHY? According to a recently filed federal securities fraud class action complaint, Power Solutions (NASDAQ: PSIX); through certain of its officers, failed to disclose to investors: (1) the Company overstated its ability to capture sales demand for its power systems solutions, particularly within the data center market; (2) the Company understated the impact of its enhancements to manufacturing capacity to meet demand within the data center market, including the expected costs and the nature of the related “inefficiencies”; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
WHAT CAN YOU DO NOW? If you purchased or otherwise acquired Power Solutions International, Inc. (NASDAQ: PSIX) securities prior to May 8, 2025, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever. Visit https://grabarlaw.com/the-latest/psix-shareholder-investigation/, contact Joshua H. Grabar at [email protected], or call 267-507-6085 to learn more. #PSIX $PSIX #PowerSolutions
Attorney Advertising Disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: [email protected]
New York, New York--(Newsfile Corp. - May 19, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hercules Capital, Inc. (NYSE: HTGC) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Hercules securities between May 1, 2025 and February 27, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/HTGC.
Hercules Case Details
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants failed to disclose to investors:
(1) the Company overstated the due diligence with which it conducted its deal sourcing and/or loan origination process;
(2) the Company overstated the due diligence with which it conducted its portfolio valuation process;
(3) the Company reported misclassified portfolio investments;
(4) as a result of the foregoing, the Company overstated and/or misrepresented its portfolio valuations; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
What's Next for Hercules Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/HTGC. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Hercules you have until May 19, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to Hercules Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Hercules Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/295301
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hercules Capital, Inc. (“Hercules” or the “Company”) (NYSE: HTGC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Hercules and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until May 19, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Hercules securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
On February 27, 2026, Hunterbrook Media published a short report entitled “The Myth of Hercules Capital.” The report alleged that, “according to a former Hercules analyst who worked on deal sourcing” the Company’s process for deal sourcing essentially amounted to “[g]o[ing] on the website for Google Ventures and just see what they invest in and just copy it.” The report stated, according to a former employee, deal sourcing managers “don’t want anything else,” and essentially just rely on other investors to have done due diligence, instead of doing their own. The report continued, revealing that, “once Hercules makes the loans, the valuation process itself may warrant scrutiny,” as “[a] former member of Hercules’ finance team described a small, overstretched team with few checks in place.” This second former employee revealed the valuations team “consisted of just four people in a single reporting line responsible for dozens of companies,” with “few checks or cross-team review.” The former employee noted this was contrary to how things were done at other public companies where, in contrast “[t]here is a strong push to do things the right way, to reinvent, to make sure that we’re double-checking, triple-checking.” The report stated the former employee found this was not the case at Hercules. The report also alleged that Hercules Capital underrepresents its significant software debt exposure. The report stated the Company does this, in part, by “assign[ing] certain businesses that describe themselves as software companies to categories outside of software.” The report also cast doubt on to the Company’s book value, which marks its software debt “at 100 cents on the dollar” despite “billions worth of [software] debt across the industry falling into distressed territory.”
Following publication of the Hunterbrook report, Hercules’s stock price fell $1.22 per share, or 7.91%, to close at $14.21 per share on February 27, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
New York, New York--(Newsfile Corp. - May 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hercules Capital, Inc. (NYSE: HTGC) between May 1, 2025 and February 27, 2026, inclusive (the "Class Period"), of the important May 19, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Hercules Capital securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Hercules Capital class action, go to https://rosenlegal.com/submit-form/?case_id=56968 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 19, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Hercules Capital overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) Hercules Capital overstated the due diligence with which it conducted its portfolio valuation process; (3) Hercules Capital reported misclassified portfolio investments; (4) as a result of the foregoing, Hercules Capital overstated and/or misrepresented its portfolio valuations; and (5) as a result of the foregoing, defendants' positive statements about Hercules Capital's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Hercules Capital class action, go to https://rosenlegal.com/submit-form/?case_id=56968 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298118
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
A month has gone by since the last earnings report for Hercules Capital (HTGC - Free Report) . Shares have lost about 7.4% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Hercules Capital due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.
Hercules Capital Q1 Earnings Beat Estimates on Record New CommitmentsHercules Capital’s first-quarter 2026 net investment income of 48 cents per share beat the Zacks Consensus Estimate by a penny. The bottom line grew 6.7% from the year-ago quarter.
Results primarily benefited from an increase in the total investment income and record new commitments. The balance sheet position remained decent. However, a rise in operating expenses was a headwind.
Net investment income was $88.1 million, up 13.8% year over year.
Total Investment Income Improves, Expenses RiseTotal investment income in the quarter was a record $141.5 million, rising 22.5% from the year-ago quarter. The top line surpassed the Zacks Consensus Estimate of $138 million.
Total quarterly gross operating expenses increased 28.1% to $58.1 million. The rise was due to an increase in almost all cost components except for general and administrative expenses.
Portfolio Value & New Commitments SolidThe fair value of Hercules Capital’s total investment portfolio was $4.72 billion as of March 31, 2026.
In the first quarter, the company delivered a record $1.81 billion in gross new debt and equity commitments and $706.4 million in total new funding. It realized early loan repayments of $225.8 million. This, along with scheduled amortization of $1.7 million, led to total debt repayments of $227.5 million.
Balance Sheet Position DecentAs of March 31, 2026, Hercules Capital’s net asset value was $11.90 per share, down from $12.13 as of Dec. 31, 2025.
As of March 31, 2026, the company had $454.5 million in liquidity, including $42.4 million of unrestricted cash and cash equivalents, and $412.1 million in credit facilities.
At the end of the quarter, the weighted average cost of borrowings, comprising interest and fees, was 5.1%, up from 4.9% at the end of the prior-year quarter.
OutlookManagement expects prepayments to be in the range of $350-$500 million in the second quarter of 2026.
The company expects core yields in the second quarter of 2026 to be 12-12.5%.
Originations are expected to moderate in the second quarter.
Interest expenses in the second quarter are expected to increase compared to the previous quarter based on debt portfolio growth.
The company expects gross selling, general and administrative (SG&A) expenses to be in the $27.5-$28.5 million range in the second quarter of 2026.
A Registered Investment Advisor (RIA) expense allocation of roughly $4.5 million is expected to be incurred in the second quarter.
The company expects a quarterly dividend from the RIA of approximately $2-$2.5 million per quarter in 2026.
How Have Estimates Been Moving Since Then?Analysts were quiet during the last two month period as none of them issued any earnings estimate revisions.
VGM ScoresAt this time, Hercules Capital has a poor Growth Score of F, a grade with the same score on the momentum front. Charting a somewhat similar path, the stock has a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook Hercules Capital has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Hercules Capital is a strong buy, trading at a rare 28.4% NAV premium versus its 5-year average of 49.36%. HTGC offers a 12.3% dividend yield, with distributions well covered by net investment income and supported by $149.1M in spillover income. The portfolio is conservatively structured, with 98% floating-rate senior secured loans and non-accruals at just 0.1% of fair value.
-- $135 million equity financing with participation from leading specialist investors, corporate investors, and long-term growth partners, including Wellington Partners, JIC Venture Growth Investments (JIC VGI), Founders Fund, Narya Capital, Eisai Co., Ltd., and other select institutional investors
-- Up to $165 million in flexible, non-dilutive capital, including $110 million senior-secured debt facility and $55 million of royalty financing with Hercules Capital, Inc.
-- Financing will support investments in commercial readiness activities for adrabetadex ahead of its November 17, 2026, Prescription Drug User Fee Act (PDUFA) target action date. This will include the development of a long-term patient access and family support program designed to reduce the burden for those living with infantile-onset Niemann-Pick disease, type C (I-NPC) throughout their treatment journey.
-- This transaction positions Beren to become financially self-sustaining through the potential commercialization of adrabetadex, while providing the flexibility to invest in long-term growth initiatives
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Beren Therapeutics P.B.C., the parent company of Mandos LLC and a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, today announced it has secured $300 million in combined financing.
The financing includes a $135 million equity financing alongside up to $165 million in a strategic financing facility with Hercules Capital, Inc. (NYSE: HTGC) across a senior secured debt and royalty structure. Capital will support Beren’s growth strategies, including the potential U.S. commercial launch for adrabetadex to treat I-NPC and investments in patient access infrastructure and family support resources.
“I-NPC reshapes family life. Families have consistently told us that their burden extends far beyond the availability of therapies, and that there remains a substantial unmet need for long-term support as families navigate diagnosis, treatment decisions, specialist care, reimbursement, and changing needs over a multi-decade journey with this disease,” said Jason Camm, Founder and Chief Executive Officer at Beren. “Our vision is not only to develop new treatment options, but also to help address the broader challenges families face throughout their journey. We are pleased to be joined by a world-class group of investors who share that vision and our conviction in what may now be possible for this community.”
I-NPC is the most severe, rapidly progressive form of NPC, a rare, always fatal, pediatric neurodegenerative disease characterized by impaired intracellular cholesterol trafficking. If approved, adrabetadex would represent a first-in-class, disease-modifying treatment for I-NPC and be the only therapy approved to directly act on the accumulated intracellular cholesterol that drives the disease. The U.S. Food and Drug Administration (FDA) accepted Beren’s New Drug Application for the investigational therapy, adrabetadex, which is under Priority Review with a PDUFA target action date of November 17, 2026.
Use of proceeds
Financing proceeds will support a comprehensive set of programs in anticipation of a potential approval and launch of adrabetadex that best provides access and meaningful support to the NPC community, including:
Accelerating diagnosis to support early intervention Providing a single point of contact for families Ensuring local access to sites of care Generating longitudinal real-world evidence and shared learning Strengthening peer-to-peer learning and community connectivity “Infantile-onset NPC is a disease that takes children from their families faster than almost any parent can comprehend. For decades, families in our community have lived with the day-to-day complexity of caring for a child with a progressive neurodegenerative disease – coordinating across specialists, navigating insurance, and managing care that touches every part of family life,” noted Garland Alvey, Executive Director and Founder of ‘AbbyStrong Fights NPC,’ Board Member of the National Niemann-Pick Disease Foundation, and Trustee of the International Niemann-Pick Disease Registry. “Continued commitment from companies and investors to advance new therapies and to build the support systems families actually need is what gives our community reason to believe the path forward keeps getting better.”
Financial transactions
The $135 million equity financing brought together a concentrated group of specialist healthcare investors, long-term growth partners, and strategic investors, including Wellington Partners, JIC Venture Growth Investments (JIC VGI), Founders Fund, Narya Capital, Eisai Co., Ltd., and other select institutional investors. The financing supports Beren’s long-term global strategy, including preparations for the potential commercial launch of adrabetadex and continued investment in patient access, family support, and care infrastructure for the infantile-onset NPC community.
Concurrent with the equity financing, Beren entered a $165 million non-dilutive financing agreement with Hercules Capital, Inc. to provide the company greater financial flexibility at a lower blended cost of capital, comprised of:
Up to $110 million in term loans based on regulatory and revenue milestones, of which $30 million is currently drawn A $55 million royalty financing to be funded upon FDA approval of adrabetadex. The royalty financing carries a 7.5% royalty on U.S. net sales and a 5% royalty on net sales outside the U.S. of adrabetadex, up to a 1.75x cap through 2031 and with the ability to redeem at a lower multiple in the first two years “Hercules is proud to partner with Beren as they prepare for the potential launch of adrabetadex for children with infantile-onset NPC. Jason and the Beren team have built a company with deep conviction in the science and a clear-eyed plan to ensure this therapy reaches all families who need it. We are pleased to provide the capital to support that work, and Beren’s continued evolution over the coming years,” said Cristy Barnes, Managing Director at Hercules Capital.
Morgan Stanley & Co. LLC acted as sole structuring agent on the transactions. Wilson Sonsini Goodrich & Rosati served as legal advisor to Beren, and Latham & Watkins advised Hercules.
About Infantile-Onset Niemann-Pick Disease, Type C
Niemann-Pick disease, type C (NPC) is a rare, autosomal-recessive, severe, heterogeneous, neurodegenerative disorder caused by pathogenic variants in the NPC1 (~95% of cases) or NPC2 genes, leading to impaired intracellular cholesterol trafficking resulting in progressive neurological decline and premature mortality. Infantile-onset NPC (I-NPC) refers to NPC in infants and children who first experience neurological symptoms <6 years of age. Earlier neurological onset is associated with more rapid progression and poorer prognosis, with mean ages of death of ~5.6 years for early infantile-onset (age of neurological onset <2 years) and ~13.4 years for late-infantile onset (2 to <6 years).
About Adrabetadex
Adrabetadex is a proprietary mixture of 2-hydroxypropyl-β-cyclodextrin isomers under investigation as a treatment for Niemann-Pick disease, type C (NPC). The data suggest that by re-establishing intracellular cholesterol trafficking, adrabetadex is designed to directly address the underlying pathology of NPC. Data from clinical trials and expanded access programs suggest that adrabetadex is generally well tolerated. The main adverse events associated with adrabetadex include hearing impairment that can be managed with hearing aids when necessary, and post-dose fatigue and/or ataxia.
The U.S. Food and Drug Administration (FDA) granted adrabetadex Breakthrough Therapy Designation. In February 2026, the FDA accepted Beren Therapeutics’ New Drug Application (NDA) for adrabetadex in infantile-onset NPC for Priority Review. The agency assigned the NDA a Prescription Drug User Fee Act target action date of November 17, 2026. Adrabetadex has not been approved by the FDA or any other health authority at this time.
About Beren Therapeutics P.B.C.
Beren Therapeutics P.B.C. is a founder-led biotechnology company pioneering the discovery, development, and commercialization of cyclodextrin-based therapeutics for conditions characterized by defective cholesterol trafficking. Beren’s first program, adrabetadex, is under U.S. Food and Drug Administration review with a Prescription Drug User Fee Act target action date of November 17, 2026, for the treatment of infantile-onset Niemann-Pick disease, type C (I-NPC). Beren and its subsidiary Mandos LLC have supported the NPC community since 2021 through an Expanded Access Program and are preparing for the U.S. commercial launch of adrabetadex, if approved, with a comprehensive set of patient access and family support programs.
Beren’s public benefit purpose is to discover, develop, and deliver novel therapies that provide optimal benefit for patients, and to do so by integrating the needs of patients, caregivers, clinicians, and health systems from the beginning of the development process and maintaining a long-term focus on delivering meaningful therapies and access.
Beren is headquartered in Thousand Oaks, Calif. To learn more about Beren, the adrabetadex program, and Beren’s cholesterol-trafficking focused therapeutic strategy, visit the company’s website at: https://www.BerenTx.com/ or follow Beren on LinkedIn.
About Hercules Capital
Hercules Capital, Inc. (NYSE: HTGC) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broad variety of technology and life sciences industries. Since inception (December 2003), Hercules has committed more than $27 billion to over 700 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. To learn more, visit htgc.com.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements regarding the U.S. Food and Drug Administration’s review of the New Drug Application for adrabetadex; the timing and outcome of regulatory review; the potential for adrabetadex to provide clinical benefit or to address the underlying pathology of Niemann-Pick disease, type C; the potential for approval or commercialization; the ability to continue providing access through expanded access; and Beren’s plans to expand its pipeline. Actual results may differ materially due to risks and uncertainties including those associated with clinical development, regulatory review, manufacturing, safety and efficacy outcomes, and other factors.
Rent for a studio apartment in many major coastal cities, including Seattle, Boston, New York, Miami, Los Angeles, and San Francisco, commonly falls between $2,100 and $3,200 per month. Using a midpoint of roughly $2,500 per month, that translates to about $30,000 in annual housing costs. The question is simple: how much investment capital is required to generate enough income to cover that rent, and what tradeoffs come with the strategy?
At a blended yield of 9.7%, the answer is approximately $310,000. For a disciplined saver, that target is achievable. The more important question is how that income is produced. There are several ways to reach the same $30,000 annual cash flow, but the long-term results can look dramatically different depending on the type of investments generating it.
The Three Yield Tiers Against a $30,000 Rent Bill Conservative (3% to 4%). Broad market dividend ETFs and dividend growth funds require $30,000 divided by 0.035 equals roughly $857,000 in capital. You need almost three times the money. The payoff: distributions from quality dividend growth portfolios have historically risen around 6% to 8% a year, matching or beating rent inflation. Principal tends to appreciate. You sleep at night.
Moderate (5% to 7%). Preferred share funds, diversified REIT funds, and covered call equity income ETFs. $30,000 divided by 0.06 equals $500,000. Distributions are higher, but dividend growth slows and covered call structures cap upside in rising markets. Income holds up; purchasing power slowly erodes.
Aggressive (8% to 14%). This tier matches the $310,000 thesis. Business development companies, mortgage REITs, leveraged covered call funds, and high-yield bond funds. $30,000 divided by 0.097 lands at roughly $310,000.
What a $310,000 Aggressive Portfolio Holds A representative allocation would lean on 40% covered call equity income, 25% BDCs, 20% mortgage REITs, 10% high-yield bond funds, and 5% preferred shares. The BDC and mREIT sleeves do the heavy lifting on yield.
On the BDC side, Ares Capital (NASDAQ:ARCC | ARCC Price Prediction) reported Q1 2026 total investment income of $763 million, core EPS of $0.47, NAV per share of $19.59 and declared a $0.48 Q2 2026 dividend. Main Street Capital (NYSE:MAIN) pays monthly: $0.26 a month plus a 19th consecutive $0.30 quarterly supplemental. Hercules Capital (NYSE:HTGC) posted record Q1 2026 investment income of $141.5 million and guided to a 12.0% to 12.5% core yield.
On the mortgage REIT side, AGNC Investment pays $0.12 monthly, but Q1 brought a net loss of $0.17 a share and tangible book value down 5.6% to $8.38. Annaly Capital Management booked EAD of $0.76 against a $0.70 quarterly dividend, with book value sliding from $20.21 to $19.82. Starwood Property Trust maintained its $0.48 quarterly dividend for over a decade, but distributable EPS came in at $0.39, missing $0.44. The payout now exceeds earnings, a sustainability flag worth watching.
The Long-Term Problem Most Renters Overlook The income math works on day one. The challenge emerges over time. Rents in many large coastal cities have historically increased by roughly 3% to 5% per year, while high-yield income investments often produce distributions that remain flat or gradually decline. A portfolio generating $30,000 annually may still be producing that same amount a decade later, even as the rent it was designed to cover has climbed to $40,000 or more per year.
A dividend-growth strategy follows a different path. The same $310,000 invested in a portfolio yielding 3.5% would generate only about $10,850 in income during the first year. If those dividends grow consistently over time, however, the income stream can expand substantially, reaching roughly $23,000 annually within about 12 years and continuing to grow thereafter. For younger investors with a long time horizon, growing income may ultimately prove more valuable than maximizing current yield. Investors approaching retirement, on the other hand, may reasonably prioritize higher immediate income if covering near-term expenses is the primary objective.
Three Things to Do With This Math Verify your actual rent number. Pull current Zumper, Apartment List, or Zillow data for your city. A $2,200 studio in Miami and a $3,100 studio in San Francisco produce very different capital requirements at the same yield. Compare a 10-year total return chart. Line up a BDC or mortgage REIT fund against a quality dividend growth ETF over the last decade. The compounding gap on total return usually exceeds the current yield gap. Model the tax bill and consider a Roth. BDC and REIT distributions are largely taxed as ordinary income rather than as qualified dividends. Holding the aggressive sleeve inside a Roth IRA can eliminate a 24% or 32% federal haircut, changing after-tax yield meaningfully. $310,000 covers the rent today. Whether it covers the rent in 2036 depends entirely on which tier you pick.
Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both DiamondRock Hospitality (DRH) and EastGroup Properties (EGP). But which of these two stocks presents investors with the better value opportunity right now?
